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Social impairment is frequently associated with mitochondrial dysfunction and altered 
neurotransmission. While mitochondrial function is crucial for proper brain 
homeostasis, it remains unknown whether mitochondrial disruption contributes to 
social behavioral deficits. Here, we show that Drosophila mutants in the homolog of 
the human CYFIP1, which is linked to autism and schizophrenia, exhibit mitochondrial 
hyperactivity and altered group behavior. We reveal a biologically relevant 
mechanism, how GABA availability is regulated by mitochondrial activity and its 
contribution to behavior and brain metabolism. Specifically, increased mitochondrial 
activity causes a sequestration of GABA in the mitochondria, reducing GABAergic 
signaling and resulting in social deficits. Pharmacological and genetic manipulation of 
mitochondrial activity or GABA signaling corrects the observed abnormalities. We 
identify the mitochondrial transporter Aralar, which explains how increased 
mitochondrial activity sequesters GABA. This study increases our understanding of 







Human brains, which account for only 2% of overall body weight, use 20 percent of all 
mitochondrial energy (Castro et al., 2018; Mergenthaler et al., 2013). To fulfill these 
energy requirements, mitochondria supply neurons with energy by generating 
metabolites via the tricarboxylic acid (TCA) cycle and ATP through oxidative 
phosphorylation (OXPHOS) (Hollis et al., 2017; Vos et al., 2010). Neurons critically 
depend on mitochondrial function for a variety of processes, including neurogenesis, 
synaptic plasticity and neurotransmission (Kann and Kovacs, 2007; Khacho and 
Slack, 2018; Li et al., 2004; Marland et al., 2016; Raefsky and Mattson, 2017; 
Schwarz, 2013; Vos et al., 2010; Yang et al., 2012). During synapse formation the bi-
directional flux of pre-synaptic mitochondria is increased (Badal et al., 2019). 
Furthermore, mitochondria regulate calcium buffering, controlling the release of 
neurotransmitters from neurons and ensuring proper synaptic functioning (Williams et 
al., 2013), emphasizing the importance of mitochondrial function during development 
and in the adult brain (Khacho and Slack, 2018; Picard, 2015; Son and Han, 2018).  
Converging lines of evidence support a role for mitochondria in brain dysfunctions 
such as autism spectrum disorder (ASD), schizophrenia (SCZ) and other disabilities 
(Castora, 2019; De Rubeis et al., 2014; Gandal et al., 2018; Garcia-Cazorla et al., 
2018; Hollis et al., 2017) featuring synaptic dysfunctions. 
Mitochondrial dysfunction has been observed in ASD with a prevalence of 
approximately 5-8% (Ghanizadeh et al., 2013; Griffiths and Levy, 2017; Legido et al., 
2013; Patowary et al., 2017; Rossignol and Frye, 2012; Toker and Agam, 2015; Valenti 
et al., 2014) and in SCZ (Akarsu et al., 2014; Taurines et al., 2010). Respiratory 
complex activity deficiencies as well as aberrant over-activity have been observed in 
ASD children (Fryea, 2011; Goldenthal et al., 2015) and patients with SCZ. A positive 
correlation between mitochondrial complex I and III mRNA levels has also been 
reported in SCZ (Akarsu et al., 2014; Taurines et al., 2010) and in individuals with 
psychotic symptomatology (Bergman and Ben-Shachar, 2016), though other studies 
have shown the opposite, namely impaired mitochondrial network dynamics 
associated with reduced cellular respiration and complex I abnormalities in SCZ 
(Rosenfeld et al., 2011). Furthermore, clinical studies have associated metabolic 
disturbances, including mitochondrial dysfunction at the levels of mtDNA, activity, 
atypical redox metabolism and differences in metabolites in patients with ASD and 




Mitochondrial genes have been reported to be differentially expressed in the cerebral 
cortex of ASD patients and strongly correlated with genes associated with synaptic 
transmission (Schwede et al., 2018), and in SCZ, disruptions in mitochondria have 
been found in different brain regions, cell types and subcellular locations (Konradi and 
Ongur, 2017). Recently, a human whole genome methylation study revealed that two 
crucial biological processes, mitochondrial metabolism and protein ubiquitination, 
associated with ASD brains (Stathopoulos et al., 2018). In agreement, a GWAS study 
showed a significant enrichment for ASD and SCZ-associated common variants in 
genes that regulate synapse & mitochondrial homeostasis (Gandal et al., 2018). While 
these studies suggest a potential association between energetic balance, synaptic 
transmission, and psychiatric disease, the functional significance of mitochondrial 
disturbances to neurological disease, and the mechanistic links between these 
processes, remains unclear.  
 
Copy number variations (CNVs) and single nucleotide variants (SNVs) in the CYFIP1 
gene have been associated with SCZ and ASD (Leblond et al., 2012; Stefansson et 
al., 2014; Tam et al., 2010; Vanlerberghe et al., 2015; Wang et al., 2015; Zhao et al., 
2013). Furthermore, genomic instability at the 15q11.2 BP1-BP2 locus, which 
encompasses four genes including the Cytoplasmic FMR1 interacting protein 1 
(CYFIP1), has also recently emerged as a recognized syndrome  (Cafferkey et al., 
2014; Cox and Butler, 2015; De Wolf et al., 2013; Nevado et al., 2014; Urraca et al., 
2013; Williams et al., 2019; Yuen et al., 2017). Among the 4 implicated genes, 
converging evidence suggest that CYFIP1 is a key factor mediating risk for the BP1-
2-deletion disorders (Das et al., 2015; Nebel et al., 2016; Vanlerberghe et al., 2015; 
Wang et al., 2015; Woo et al., 2016; Yoon et al., 2014). CYFIP1 has a dual role in the 
brain, regulating local protein synthesis via binding eIF4E and controlling actin 
remodeling as part of the hetero-pentameric Wave Regulatory Complex (WRC) (Anitei 
et al., 2010; Chen et al., 2010b; De Rubeis et al., 2013; Di Marino et al., 2015; Eden 
et al., 2002; Genheden et al., 2015; Hsiao et al., 2016; Napoli et al., 2008; Oguro-Ando 
et al., 2015; Panja et al., 2014; Pathania et al., 2014; Schenck et al., 2003; Stradal 
and Scita, 2006). Moreover, recent studies demonstrated that CYFIP 
haploinsufficiency in humans, mice and flies confers domain-specific cognitive 
impairments and behavioral deficits (Bachmann et al., 2019; Bozdagi et al., 2012; 




molecular mechanisms linking CYFIP1 deficiency with alterations in behavior and 
cognition remain unknown.  
 
Here we investigated the molecular mechanism underlying social behaviors in 
Drosophila, demonstrating a mechanistic link between alterations in mitochondrial 
metabolism, neuronal communication and social behavior. Using Cyfip 
haploinsufficient flies we show that an increase in mitochondrial activity, energy 
metabolism and membrane potential causes abnormal GABA signaling, leading to 
deficits in social group interactions in flies. Furthermore, we identify the solute carrier 
Aralar as the mitochondrial transporter responsible for the uptake of GABA into 
mitochondria which is activated by mitochondrial membrane polarization. We provide 
genetic, biochemical, pharmacological and morphological evidence that explains how 
dysregulation of mitochondria homeostasis regulates GABA signaling and the social 








Cyfip85.1/+ flies have deficits in social behavior  
CYFIP haploinsufficiency in humans and flies has recently been shown to confer 
domain-specific cognitive impairments (Woo et al., 2019). Because increasing 
evidence points towards a role of CYFIP1 in ASD- and SCZ like behaviors 
(Domínguez-Iturza et al., 2019; Silva et al., 2019), and given the prevalence of social 
deficits in these disorders, we investigated if CYFIP haploinsufficiency affects ASD-
like behaviors focusing in well-established paradigms for social group behavior in 
Cyfip85.1/+ and control flies (Schenck et al., 2003). First, male flies were tested in a 
food competition assay (Anholt and Mackay, 2012; Zwarts et al., 2011) where the 
index of approaches was used to obtain an average of the total number of social 
events in a 2 minutes time frame. Cyfip85.1/+ male flies showed a reduced number of 
social events relative to control flies (Figure 1A and Supplementary movies 1 and 2). 
This holds also true for female flies (Figure S1A). Second, social performance of the 
Cyfip85.1/+ flies was further investigated by observing Drosophila courtship, a complex 
innate social behavior in flies (Ejima and Griffith, 2007; Sokolowski, 2010). Cyfip85.1/+ 
male flies showed a decreased courtship index towards a wild type female (Figure 1B 
and Supplementary movies 3 and 4). Third, we monitored grooming behavior of 
individual flies in an observation chamber (Tauber et al., 2011). Cyfip85.1/+ male flies 
showed an excess of grooming behavior in comparison to control flies (Figure 1C and 
Supplementary movies 5 and 6) suggesting an increase in repetitive behavior. 
Moreover, we recorded behavior of flies within a social group, measuring the distance 
between two flies as social space (Simon et al., 2012). Cyfip85.1/+ flies, on average, 
show longer distance to the closest neighbor fly in comparison to control flies within a 
group (Figure 1D) confirming further the social interaction impairment of Cyfip85.1/+ 
flies. In addition, Cyfip85.1/+ flies stayed further away from the wall of the open field 
arena (Figure 1D), indicating their natural thigmotactic behavior (attraction to the 
contact of the wall) (Besson and Martin, 2005) is also disturbed. Cyfip85.1/+ flies exhibit 
hyperactivity overs 24 hours when compared to controls (Figure S1B), but no 
differences in locomotion activity were observed during the day time (ZT0-ZT6) (Figure 
S1C), the timeframe that the social assays were performed. This indicates that 
hyperactivity does not interfere with our social behavioral assays and the observed 




females) do not differ from the controls (Figure S1D and E) in negative geotaxis as 
measurement for motor reflex (Sun et al., 2018), anxiety (Garcia and Teets, 2019) or 
startle response (Zhang et al., 2002). Then, we used the TARGET system to 
interrogate temporal and regional specific effect of dCyfip knock-down by transgenic 
RNAi (UAS-CYFIP-IR) expression in the adult animal (McGuire et al., 2003). Pan-
neuronal attenuation of Cyfip mRNA levels in adult flies (Figure S1F) phenocopied the 
decreased competition for food in Cyfip85.1/+ mutant animals (Figure S1G). 
Importantly, the decreased social score in the Cyfip85.1/+ flies was fully rescued by 
expression, in adulthood only, of a transgene harboring the wild type Cyfip (UAS-
CYFIP-WT/genetic rescue) (Figure S1G). These data provide evidence that CYFIP is 
required to mediate social behavior in adult flies.  
 
Proteomic analysis of Cyfip85.1/+ mutant reveals deficits in mitochondrial 
pathways and disease networks  
To identify the molecular mechanism underlying the observed behavioral dysfunctions 
in the Cyfip85.1/+ flies, we performed tandem mass spectrometry in control and 
Cyfip85.1/+ mutant brains. Analysis identified a total of 345 dysregulated proteins, of 
which 309 were present at greater abundance and 36 at lower abundance in Cyfip85.1/+ 
flies compared to controls (Table S1). The identified proteins corresponded to 361 fly 
genes and mapped with high confidence to 264 human orthologs (i.e. 73%). Fly 
protein-protein interaction (PPI) and cluster networks were then constructed by mining 
publicly available databases: FlyBase (Attrill et al., 2016), BioGRID, IntAct, BIND, DIP 
(Salwinski et al., 2004), and MINT (Salwinski et al., 2004) (Figure 2A). The strongest 
signal recovered in these network-based analyses was for the community of 
mitochondrial proteins (Community 3, p = 2.4 x 10-6, permutated p-value<1%). This 
mitochondrial signal was likewise one of the top hits in the gene ontology analysis, 
identifying differentially expressed mitochondrial proteins (Figure 2B and Table S2) 
and highlighting dysregulation of TCA cycle, energy metabolism and mitochondrial 
electron transport, as well as neurotransmitter release related processes (Figure 2C 
and Figure S2). Further, disease-related analyses identified a highly significant 
overrepresentation of gene networks implicated in SCZ, dementia, and syndromic 





Cyfip85.1/+ flies show increased brain mitochondrial size and respiration  
Given that our proteomic analysis suggested a role for mitochondria and energy 
metabolism in the Cyfip85.1/+ flies, we assessed whether the mutant flies showed any 
alterations in mitochondrial respiration. Using high-resolution respirometry, we 
observed a striking increase in mitochondrial respiratory capacity through the 
respiratory chain in Cyfip85.1/+ brains (Figure 3A), both at the level of coupled 
respiration through complexes I and II (Complex I (CI) and Complex I+II (CI+II) and at 
the level of maximal electron transfer capacity (CI+II ETS) (Figure 3B). The respiration 
differences appear to be driven by complex I and complex IV (COX), because no 
difference was detected upon specific blockage of complex I (Figure 3B). In contrast, 
no alterations were observed in the oxygen consumption in Cyfip85.1/+ fly body (Figure 
3C), suggesting that mitochondrial activity is specifically dysregulated in the CNS. The 
labeling brains with tetramethylrhodamine ethyl ester (TMRE), an established marker 
for mitochondrial membrane potential (Perry et al., 2011), revealed an increased 
signal intensity in the Cyfip85.1/+ brains, further suggesting that the flies exhibit 
increased mitochondrial membrane potential (Figure 3D). This finding was also 
confirmed by Rhodamine 123 staining (Figure S3A). No differences were observed in 
mitochondrial DNA (mtDNA) copy number or abundance of mitochondrial proteins 
between Cyfip85.1/+ mutants and controls (Figure 3E, Figure S3B-C). To independently 
validate this finding, we used another widely used marker of mitochondrial 
activity/mass, the citrate synthase (CS) activity (Spinazzi et al., 2012). CS activity in 
Cyfip85.1/+ mutants was not altered in comparison to control brains (Figure S3D). Next, 
mitochondrial morphology was analyzed by Tandem Electron Microscopy (TEM) in fly 
brain from both genotypes and a remarkable difference was observed in the mutant 
flies. Precisely, mitochondria area and perimeter were increased in Cyfip85.1/+ mutant 
flies in comparison to controls (Figure 3F), which is indicative of higher mitochondrial 
activity (see Discussion). The higher metabolic rate of Cyfip85.1/+ flies is not due to 
higher food consumption, as feeding behavior during the day time (Figure S3E) and 
over 24 hours (Figure S3F) was not altered. In conclusion, these data reveal that the 







Cyfip85.1/+ flies have an excessive TCA/Krebs cycle  
The high enrichment of proteins relating to mitochondrial function (OXPHOS and TCA 
cycle) in the mass spectrometry dataset (Figure S2), and the demonstration of 
increased mitochondrial membrane potential in the Cyfip85.1/+ fly brain, prompted us 
to investigate whether Cyfip85.1/+ flies have any alterations in the TCA cycle (Krebs or 
citric cycle), which produces the substrates for oxidative phosphorylation for energy 
production. First, TCA metabolites (Figure 4A) were determined by stable-isotope-
dilution Liquid Chromatography Mass Spectrometry (LC-MS) from Cyfip85.1/+ brains. 
Of the metabolites that are produced in the TCA cycle itself, isocitrate, 2-oxoglutarate 
(α-ketoglutarate, α-KG) and succinate levels are increased, indicating that enzymatic 
activity/ies in this section of the cycle are higher (Figure 4B). Of note, α-ketoglutarate 
and succinate generate two of the three NADH molecules, which serve as fuel for 
complex I oxidation, suggesting that upregulation of the TCA cycle is responsible for 
the increased complex I activity we observe in the Cyfip85.1/+ brain (Figure 3B) 
(Maguire et al., 2015). Examination of the mass spectrometry data further validated 
that the levels of NADH-producing enzymes, specifically the NAD-dependent isocitrate 
dehydrogenase (IDH) (Yoon et al., 2017) and the α-ketoglutarate hydroxylase, are 
indeed upregulated (Table S2). NAD-IDH activity increased 3-fold in Cyfip85.1/+ brains 
in comparison to controls (Figure 4C), and the activity of α-KG-dependent hydroxylase 
was also significantly increased in Cyfip85.1/+ brains (Figure 4D). Interestingly, the total 
levels of the oxidized and reduced forms of nicotinamide adenine dinucleotide (NADt: 
NAD+ and NADH) were not altered between Cyfip85.1/+ and controls in isolated 
mitochondria (Figure 4E), however the reduced form (NADH), had a significantly 
higher level (Figure 4F). Tracing of 13C-labelled glucose shows a drastic increase of 
isotope-labelled succinate in Cyfip85.1/+ flies, while incorporation of the 13C-label into 
to malate and citrate/isocitrate does not change in the two genotypes (Figure 4G). This 
confirms that the biochemical reactions between citrate/isocitrate and succinate, i.e., 
IDH and αKG, are overactive and shows that the TCA cycle overactivity is fed by 
glycolysis. Further analysis of the amino acid composition using stable isotope tracing 
as well as HILIC-MS/MS, revealed higher levels of amino acids related to the TCA 
cycle in Cyfip85.1/+ brains (Figure S4A, B). These findings confirm that the Cyfip85.1/+ 





The deficit in social behavior in Cyfip85.1/+ flies is energy-dependent  
Given that Cyfip85.1/+ flies have altered social behaviors and increased mitochondrial 
respiration we next tested whether the alterations in mitochondrial function were 
causally involved in mediating the behaviors seen in the Cyfip85.1/+ flies. At first, we 
normalized energy production by reducing IDH activity to partially inhibit the TCA 
cycle. Using Idh3a mutant flies, which have decreased IDH activity and reduced α-
ketoglutarate levels (Ugur et al., 2017), we found that social behavior in the food 
competition assay was reduced in idh3a/+ flies, and that the double idh3a/+;Cyfip85.1/+ 
behaved as controls (Figure 5A). Further, pharmacological inhibition of IDH activity 
using the ML309, a selective inhibitor of IDH that effectively lowers the production of 
α-ketoglutarate levels (Davis et al., 2014), also ameliorated the abnormal social 
feeding behavior in Cyfip85.1/+ flies (Figure 5B). Interestingly, idh3a /+ single mutant or 
overexpression of IDH in fly brain (Figure 5C) showed a reduction in social behavior 
similar to the Cyfip85.1/+ flies, suggesting that both too much and too little energy 
production leads to a social behavioral defect. Importantly, the ML309 compound also 
restored the increased mitochondrial activity in the Cyfip85.1/+ flies (Figure 5D). These 
results demonstrate a novel association of social behavior with the TCA cycle, and 
highlight the importance of the IDH enzyme as a potential therapeutic target. 
We next designed an experiment to test whether dampening mitochondrial activity and 
mitochondrial membrane potential might also normalize social behavior. Control and 
Cyfip85.1/+ flies were fed with rotenone (an inhibitor of complex I) for 4 days at a 
concentration of approximately 500 times less than that used to model Parkinson 
disease in flies. Although this treatment had no effect on the behavior of wild type flies 
(Figure S5A), we found that it ameliorates social deficits in Cyfip85.1/+ mutants (Figure 
5E) after 4 days of feeding. The effect of rotenone treatment was reversible (Figure 
S5B). Of note, the same treatment did not restore the hyperactivity of Cyfip85.1/+ 
mutants (Figure S5C), suggesting that the mitochondrial phenotype is specific to social 
behavior. Moreover, reducing complex I activity by crossing Cyfip85.1/+ flies to flies with 
a genetic reduction of complex I activity (Pink1B9/+ mutants; (Morais et al., 2009) also 
rescued social behavior to levels that were indistinguishable from controls (Figure 5F). 
As for the Idh3a mutant, Pink1B9/+ flies exhibited social deficits similar to those seen 
in Cyfip85.1/+ mutants. Finally, western blotting analysis revealed that Cyfip85.1/+ 




(Figure S3B), consistent with the mass spectrometry data. Assessments of ndufs3/+ 
mutant flies, harboring a mutation affecting mitochondrial complex I, also uncovered 
abnormal social behavior in these flies, whereas the double ndufs3/+;Cyfip85.1/+ 
mutants were normal with regard to number of social interactions (Figure 5F). 
Combined, these results point to a novel, causal, role for mitochondria and energy 
metabolism in the regulation of a complex social behavior.  
 
Reduction of Cyfip in a subset of GABAergic neurons recapitulates the social 
interaction deficits  
Excitation/inhibition balance in micro circuitries plays an essential role in the 
pathophysiology of psychiatric disorders with shared social deficits (Benke and 
Mohler, 2017; Boccuto et al., 2013; Brambilla et al., 2003; Cellot and Cherubini, 2014; 
Coghlan et al., 2012; Edden et al., 2012; Friedman et al., 2003; Kuo and Liu, 2019; 
Mukherjee et al., 2019; Robinson and Gradinaru, 2018; Zoghbi and Bear, 2012). 
Additionally, both in ASD and SCZ, there is differential expression of mitochondrial 
genes in different brain regions, cell types and subcellular locations (Konradi and 
Ongur, 2017). Therefore, to identify whether there is any cell type sensitive to the 
identified Cyfip85.1/+, social behavior, we knocked down Cyfip individually in both major 
excitatory (cholinergic) and inhibitory (GABAergic) neurons (Hsu and Bhandawat, 
2016; Kolodziejczyk et al., 2008; Lee et al., 2003), neuronal clusters important for 
social behavior in fly brain (Koganezawa et al., 2016; Yuan et al., 2014). No effect on 
social behavior was observed when Cyfip levels were reduced in cholinergic neurons 
(Figure 6A). However, depletion of Cyfip in GABAergic neurons recapitulated the 
feeding-dependent socialization defect seen in the Cyfip85.1/+ flies (Figure 6B), and 
this could be rescued by genetic reintroduction of Cyfip1. Attenuation of Cyfip mRNA 
levels specifically in GABAergic neurons was confirmed (Figure S6A).  
The Drosophila brain contains around a thousand well-mapped GABAergic neurons 
responsible for distinct behavioral functions (Figure S6B). This allowed us to further 
investigate possible defects in the GABAergic system by assessing subsets of 
GABAergic neurons sensitive to Cyfip dosage. To do so, the GAL4 system was used 
to deplete Cyfip individually in three distinct GABAergic interneuron subtypes: in the 
anterior paired lateral neurons (APL, a single GABAergic neuron per brain hemisphere 




and Davis, 2009; Masuda-Nakagawa et al., 2014; Wu et al., 2011), in the antenna lobe 
local interneurons (LNs; whose processes are restricted to a local region), and in the 
dorsal paired medial neurons (DPMs, which project to the MB to stabilize memories). 
Reducing Cyfip levels in the APLs or LNs recapitulated behavioral deficits observed 
with pan-neuronal or pan-GABAergic knockdown, while no effect was observed for the 
DPMs (Figure 6C).  
 
Reduction of Cyfip causes GABA to accumulate in mitochondria  
Given the sensitivity of GABAergic cells to Cyfip dosage we investigated vesicular 
GABA levels in Cyfip85.1/+ flies.  Immunohistochemistry experiments (Homberg and 
Muller, 2016; Tochitani and Kondo, 2013) of Cyfip85.1/+ whole mount brains showed 
reduced vesicular GABA levels (Figure 6D). To address whether such a reduction was 
due to a pre- or post-synaptic phenotype, we monitored synaptic transmission in 
GABAergic neurons. By expressing the UAS-synaptophysin-pHTomato (Pech et al., 
2015) in GABAergic neurons (Figure 6E), we uncovered a surprising increase in 
synaptic release in GABAergic neurons of Cyfip85.1/+ flies in comparison to control flies 
(Figure 6F). Using in vivo Ca2+ imaging in the GABAergic neurons (Pech et al., 2015), 
Cyfip85.1/+ flies show no changes in Ca2+ presynaptic responses (Figure S6C). 
Furthermore, the number of GABAergic neurons, as probed by glutamic acid 
decarboxylase 1 (GAD1) staining, revealed no difference in the brains of Cyfip85.1/+ 
and control flies (Figure S6D). GAD1 mRNA and protein levels also did not change 
(Figure S6E, F). These findings prompted us to measure glutamate levels, the 
metabolic precursor of GABA, by immunohistochemistry (data not shown) and HILIC-
MS/MS (Figure S7A). No differences in glutamate levels were observed between 
Cyfip85.1/+ and control flies. Interestingly, the total concentration of GABA in Cyfip85.1/+ 
mutants was not altered compared to controls by HILIC-MS/MS (Figure 6G). 
Combined, these results suggested that the entire pool of GABA synthetized 
(metabolic, intracellular, and extracellular) is not altered. 
The increased activity of the Krebs/TCA cycle in Cyfip85.1/+ lead us to hypothesize that 
GABA might be driven into the mitochondria, supplying NADH and succinate to 
Krebs/TCA cycle (Bonnighausen et al., 2015; Carillo, 2018; Maguire et al., 2015; 
Michaeli et al., 2011). We therefore measured GABA levels by ELISA following a 
fractionation to enrich mitochondria and synaptic vesicles (Depner et al., 2014). 




was markedly higher compared to controls, reduced in the synaptic vesicles, and, as 
also observed by HILIC-MS/MS, unchanged in the total fraction (Figure 6H). The purity 
and enrichment of the mitochondria preparation was confirmed by Western blot with 
the mitochondrial marker ATP5B and the synaptic marker BRP (Figure S7B). Taken 
together, these data are consistent with the idea that a reduction of Cyfip causes a 
redistribution of GABA from a vesicular/synaptic to a mitochondrial compartment, 
supporting the elevated mitochondrial activity in Cyfip85.1/+ flies and leading to 
subsequent alterations in social behavior. 
 
GABA augmentation fully normalizes behavioral abnormalities in Cyfip85.1/+ flies 
Given that Cyfip85.1/+ flies show a redistribution of GABA from a synaptic to a 
mitochondrial compartment, that loss of Cyfip in GABArgic interneurons is sufficient to 
cause behavioral deficits, we next aimed to investigate whether the sequestration of 
GABA is causally involved in the Cyfip-related behavioral abnormalities. To do so, we 
augmented GABA levels in Cyfip85.1/+ flies in three distinct ways; via feeding flies 
GABA, DL-2,4-diaminobutyric acid (DABA, a GABA-transaminase uptake inhibitor) or 
the anticonvulsant valproic acid (VPA, induces GABA release) (Chateauvieux et al., 
2010; Coghlan et al., 2012; Reynolds et al., 2007). Feeding Cyfip85.1/+ flies for 5 days 
with GABA (Figure 6I), DABA or VPA (Figure S7C, D) ameliorated the social behavior 
deficit. Interestingly, feeding flies with GABA also rescued behavioral deficits in the 
adult pan-neuronal Cyfip85.1/+ mutants (Figure S7E). Similarly, pan-neuronal 
abrogation in adult flies of the enzyme glutamic acid decarboxylase (GAD1) for 2 days 
led to a reduced number of social events (Figure S7F). Separate experiments in adult 
wild-type flies showed that a high GABA diet actually decreased social interaction 
(Figure S7G). Furthermore, feeding flies diazepam (valium), a positive allosteric 
modulator of the GABA-A receptor, was also able to restore the social deficits of the 
Cyfip85.1/+ (Figure S7H). These data show that augmentation of GABAergic signaling 
in adult is sufficient to ameliorate the behavioral deficits in flies resulting from reduced 
Cyfip dosage. Finally, underscoring the centrality of GABAergic signaling to this 
process, we demonstrate that administration of GABA, DABA, or VPA to the 
GABAergic-specific Cyfip abrogation flies also restores social interactions (Figure 






Aralar, a novel GABA transporter, drives the excessive mitochondrial 
accumulation of GABA in Cyfip85.1/+ flies  
Our findings suggest that reduced available GABA causes the social deficits in 
Cyfip85.1/+ flies, and that the reduction in vesicular GABA is due to GABA being 
transported into mitochondria, where it is catabolized into other intermediates through 
the GABA shunt and TCA cycle. We therefore set out to determine how GABA is being 
shunted into mitochondria.  
Mitochondrial GABA transporters in eukaryotes have surprisingly not been largely 
characterized (Bonnighausen et al., 2015). However, using gene ontology analysis for 
GO:0005741 mitochondrial outer membrane (Table S3), we identified 36 candidate 
transporters in the fly and performed a genetic screen to test their effects in the 
Cyfip85.1/+ flies. Flies with mutations in the 36 putative GABA transporters were 
individually crossed with the Cyfip85.1/+ flies and tested in the food competition social 
interaction paradigm. Of the 36 putative GABA transporters tested, only the 
AralarMI07552 mutant showed a significant effect - completely rescuing the behavioral 
deficits of Cyfip85.1/+ flies (Figure 7A, B). Importantly, crossing the Cyfip85.1 fly with the 
AralarMI0755  mutant resulted in ameliorating the Cyfip85.1/+ grooming and social space 
behavior deficits (Figure 7C, D), but not their hyperactivity (Figure S8A), further 
confirming that the mitochondrial dysregulation and Aralar have a specific effect on 
social behavior. Of note, the AralarMI07552/+ mutant flies exhibit a decreased 
competition for food (Figure 7B), decreased grooming (Figure 7C) and hyperactivity 
(Figure S8A), similar to Cyfip85.1/+ flies. 
Aralar has been so far described for its function as carrier exchanging a glutamate and 
a proton (H+) from the cytoplasm for an aspartate inside the mitochondria. Of note, 
this transport stoichiometry indicates that the proton gradient drives the transport 
(Palmieri, 2013). Our genetic findings strongly suggest that Aralar is the novel GABA 
transporter. To assess whether GABA localization was affected by the mutation in 
Aralar, GABA levels were evaluated by ELISA upon fractionation of mitochondrial and 
cytosolic components. Importantly, while cytoplasmic GABA levels were increased in 
AralarMI07552/+ mutant brains, the levels and sequestration profile of GABA across the 
cytoplasm and mitochondria in the AralarMI07552/Cyfip85.1 double mutants were 
indistinguishable from controls (Figure 7E). The combined genetic and localization 




inhibition of Aralar by pyridoxal 5'-phosphate (PLP) (Amoedo et al., 2016), ameliorated 
the competition for food of the Cyfip85.1/+ flies (Figure S8B).  
To address how a reduced dose of Cyfip could change the activity of Aralar, we 
examined if Cyfip controls Aralar expression. Remakarbly, neither Aralar mRNA level 
(Figure S8C) nor its efficiency of translation, distribution of the mRNA on a 
polysomes/mRNP gradient, change (Figure S8D) suggesting that the regulation 
occurs at the level of Aralar activity. 
As a final proof of our hypothesis, we aimed at increasing the proton gradient across 
the mitochondrial membrane, which increases Aralar activity and monitor social 
behavior in a wild type fly. Flies were treated with a sublethal dose of oligomycin to 
reduce Complex V activity  (Spinazzi et al., 2012) reducing therefore the proton flux 
and increasing mitochondrial membrane potential, as confirmed by the TMRE staining 
(Figure 7F). Notably, under these conditions, the competition for food of wild type flies 
was decreased (Figure 7G) together the level of available GABA in the cytosol (Figure 
7H), resembling the Cyfip85.1/+ mutant condition. These data further support our 
previous observations that homeostasis of mitochondria GABA levels plays an 








Using a Drosophila model of Cyfip1 haploinsufficiency, a hot spot genetic variant 
proven to increase risk for SCZ and a candidate risk factor for ASD, we revealed that 
increased mitochondrial activity and membrane potential (Figure 3) reduces GABA 
availability (Figure 6) and plays a causal role in mediating social behavioral 
abnormalities (Figure 1). 
Contribution of GABA transmission to brain dysfunctions 
It has been suggested that neurodevelopmental disorders may result from an 
imbalance between the excitatory glutamatergic and the inhibitory GABAergic 
pathways (Ben-Ari, 2017; Benke and Mohler, 2017; Braat and Kooy, 2015; Cellot and 
Cherubini, 2014). Changes in inhibitory activity that lead to altered excitatory/inhibitory 
(E/I) balance in specific brain areas have been reported in patients with ASD, SCZ 
and epilepsy (Foss-Feig et al., 2017; Sohal and Rubenstein, 2019; Yizhar et al., 2011). 
Mechanistic studies in mice using optogenetic manipulations in mPFC have 
demonstrated that increasing the E/I ratio leads to social deficits, while restoration of 
E/I balance by increasing inhibition in specific GABAergic neurons (PV+) rescues the 
observed social deficits (Selimbeyoglu et al., 2017; Sohal and Rubenstein, 2019; 
Yizhar et al., 2011). In addition, treatment with benzodiazepine, which enhances 
GABA-A receptor activity, ameliorates social behavioral deficits in mouse models of 
epilepsy and ASD (Han et al., 2014; Han et al., 2012; Sohal and Rubenstein, 2019), 
consistent with our data in flies (Figure S7). Further, developmental Gabrb3 deletion 
in mouse somatosensory neurons leads to tactile sensitivity and reduced sociability 
through loss of GABA-A receptor-mediated presynaptic inhibition, pointing out the 
importance of somatosensory dysfunction in ASDs (Orefice et al., 2016). It is notable 
that CYFIP1 is enriched at inhibitory synapses and loss of CYFIP1 in rodents 
increases the E/I ratio (Davenport et al., 2019). Our work shows that augmentation of 
GABAergic signaling in adult flies, through either genetic or pharmacological 
approaches including treatment with the GABA-A receptor positive allosteric 
modulator diazepam (valium), fully normalizes abnormal social behavior (Figure S7). 
Combined, these findings suggest a common pathophysiological mechanism in these 
neurological disorders that starts with GABA impairment and leads to social deficits. 
However, despite past evidence of abnormal GABA signaling in ASD (Ben-Ari et al., 




exhibit an enrichment in ASD risk gene expression (Wang et al., 2018), until now how 
alterations in GABA and E/I balance occur in these disorders has remained less clear. 
 
Mitochondrial activity modulates GABA availability via Aralar 
Here, we demonstrate that an increase in mitochondrial metabolism causes GABA to 
be sequestered away from the synapses into the mitochondria. The translocation of 
GABA reduces the amount of GABA available for vesicular uptake (Figure 6), likely 
affecting neuronal activity. In fact, several of our observations are best explained by 
an effort of the GABAergic circuit to homeostatically correct low GABA release: the 
number of released vesicles is increased (Figure 6), and the GABA-A receptor is 
overexpressed (data not shown, see also (Davenport et al., 2019)). Reduced 
GABAergic transmission then affects behavior (Figures 1, 7). 
To enter the mitochondria, GABA needs to be transported through the mitochondrial 
membrane. To date, a mitochondrial GABA carrier has not been identified in any 
organism except in plants (Michaeli et al., 2011). Here, we screened candidate 
transporters for a rescue of the aberrant social behavior of Cyfip mutant flies, leading 
to the isolation of the protein Aralar, which we went on to show that is responsible for 
the GABA uptake into the mitochondrial in Drosophila (Figure 7). This work 
strengthens the link between mitochondrial function, GABA transmission, and social 
behavior.  
Aralar belongs to the SLC25 family, the largest family of solute transporters that 
consists mainly of mitochondrial proteins (Palmieri, 2013; Zorova et al., 2018). Aralar 
homologs are present in all metazoans (Amoedo et al., 2016), including two human 
homologs – SLC25A12 (AGC1) and SLC25A13 (AGC2). Aralar transporters have thus 
far been shown to function by exchanging an aspartate on the mitochondrial matrix for 
a glutamate plus a proton on the cytosolic side, with the pH gradient across the inner 
membrane forming the bioenergetic driving force for solute exchange. As the major 
aspartate exporter from the mitochondrion, the Aralar proteins play a major role in the 
malate-aspartate shuttle that carries redox equivalents across the mitochondrial 
membrane and thus aligns the redox potential of the mitochondria and the cytosol 
(Amoedo et al., 2016; Palmieri, 2013). Our study now indicates that Aralar can also 
transport GABA, in addition to glutamate, despite the lack of one carboxylic group that 




Neither Aralar mRNA level nor its translational efficiency changes between the two 
genotypes (Figure S8), indicating that its expression is not altered in Cyfip mutant 
brain. Instead, the activity of the Aralar transporter changes. Since Aralar needs a 
proton for import of its substrate into mitochondria, the equilibrium distribution of the 
transport substrates is set by the pH gradient across the mitochondrial membrane, 
which in turn is a function of fuel availability, oxidative phosphorylation and activity of 
the TCA cycle. In strong support of this notion, the effect we detected with oligomycin 
treatment. Oligomycin is a highly specific inhibitor of Complex V and thus selectively 
drives the pH gradient up. Oligomycin causes an accumulation of GABA in the 
mitochondria and affects social behavior (Figure 7).  
In Cyfip mutants, two key enzymes of the TCA cycle, namely IDH and αKG, are 
upregulated at the protein (Figure S2 and Table1) and activity levels (Figure 4); 
furthermore the mitochondria in the Cyfip mutant brains show a morphology (Figure 
3) that is typical of hyperactive mitochondria with a larger perimeter and area (Yao et 
al., 2019). Interestingly, we show that alterations to the TCA cycle via overexpression 
of the IDH enzyme causes social aberrations comparable to those of the Cyfip mutant 
flies (Figure 5). Further, pharmacological or genetic inhibition of the IDH enzyme 
normalizes the increased mitochondrial activity observed in Cyfip mutant flies and 
ameliorates their social deficits (Figure 5). These data serve to further support a link 
between mitochondrial function, GABA transmission, and social behavior. Additionally, 
both of the human Aralar homologs have calcium-binding motives in their cytosolic 
domain, and cytosolic calcium robustly increases transport activity (Napolioni et al., 
2011); the calcium-binding motives are conserved in Drosophila Aralar. As such, the 
local calcium rises observed during pre-synaptic vesicle release may well be sufficient 
to trigger the GABA transport process, with local mitochondria responding to reduce 
the local GABA availability. Thus, mitochondrial activity and high calcium, both effects 
of increased neurotransmission, can effectively reduce GABAergic 
neurotransmission. This suggests that under physiological conditions the Aralar-
mediated GABA sequestration process is likely to serve as a homeostatic feed-back 
inhibition mechanism. In addition, we note that every other physiological mechanism 






Disturbances of mitochondrial GABA control affects social behavior 
Our data here demonstrate a pivotal role for mitochondrial metabolism dysregulation, 
and the associated sequestration of GABA into mitochondria, in causing social 
behavioral deficits. Restoration of mitochondrial membrane potential by a variety of 
pharmacological or genetic means rescues the social behavioral deficits due to Cyfip1 
haploinsufficiency (Figure 5). Our data thus might explain in molecular terms the 
positive effect on patients with ASD and SCZ of some antipsychotic drugs such as 
haloperidol, chlorpromazine, fluphenazine or risperidone on patients with ASD and 
SCZ that act by decreasing mitochondrial respiration and membrane potential 
(Balijepalli et al., 1999).  
The Aralar mutation that increases cytosolic GABA levels (Figure 7E) also affects 
social behavior similar to the Cyfip mutation (Figure 7B,C), while the double mutation 
normalizes cytosolic GABA levels and rescues social behavior. Moreover, GABA 
administration to wild-type animals reduces social behavior (Figure S7). Taken 
together, this suggests a precarious equilibrium where too little and too much GABA 
availability is detrimental. Thus, our findings predicts that disturbances of 
mitochondrial function would cause pathological alterations in social behavior; and 
explain the link between mitochondrial dysfunction and ASD is well established 
(reviewed in (Hollis et al., 2017)). While mitochondrial dysfunction may affect the 
nervous system in various ways, our model predicts that Aralar should be specifically 
linked to social disorders. Interestingly, two ASD associated SNPs have been 
uncovered in AGC1/SLC25A12, the human Aralar isoform that is known to be 
expressed in neurons (see Aoki and Cortese, 2016, for meta analysis; Pardo et al., 
2013), and AGC1 expression is upregulated in the prefrontal cortex of ASD patients 
(Anitha et al., 2012; Lepagnol-Bestel et al., 2008). Further, disruption of the gene in 
mice causes hypomyelination and abnormal neurofilament accumulations (Sakurai et 
al., 2010); more subtle changes in AGC1 activity are thus likely to alter brain 
development and cause ASD. 
This study provides the first causal evidence linking mitochondrial energy production 
through the TCA cycle to alterations in GABA metabolism, and further uncovers a 
mechanistic link between these molecular processes and alterations in behavior in 
social groups (Figure 8). As alterations in mitochondrial metabolism are a hallmark of 
diverse neurodevelopmental disorders in humans, this mechanism could represent a 




potential to be relevant for physiological regulation of neurotransmission and also for 
a wide range of neurodevelopmental and neuropsychiatric disorders. Our study 
demonstrates that social deficits in our fly model can be rescued by pharmacological 
dampening of mitochondrial respiration, as this modulates Aralar activity. Therefore, 
molecules that specifically activate or inhibit human Aralar should be considered as 
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METHODS 
Drosophila stocks and rearing conditions. Flies were cultured in vials containing a 
standard Drosophila medium at 25 °C with 60-80% humidity in a 12h light/dark cycle. 
The fly line used as control was wild-type Canton-S w1118 (iso1CJ). Heterozygous 
mutant flies for CYFIP (Cyfip85.1/+) lacking two-third of the Cyfip-coding region were 
described previously by Schenk et al. (Schenck et al., 2003). The Cyfip85.1/+ mutant 
flies used in this study were first isogenized for 6 generations with a Cantonized w1118 
background. Regulation of CYFIP expression was achieved using the tissue specific 
GAL4/UAS system (Brand and Perrimon, 1993). In this study, to abrogate the levels 
of CYFIP we used the UAS-CYFIP-RNAi (UAS-CYFIP-IR) transgene as described 
before (Galy et al., 2011), which was linked to the Upstream Activation System (UAS). 
GAL4 in turn will bind the UAS activating transcription of CYFIP-IR. As a result, the 
RNAi construct is transcribed and endogenous Cyfip transcript will be downregulated. 
GAL4/GAL4 females were crossed en masse to UAS-CYFIP-IR/UAS-CYFIP-IR males 
to generate GAL4/UAS-CYFIP-IR progeny. GAL4/GAL4 and UAS-CYFIP-IR/UAS-
CYFIP-IR females were also crossed with w1118 males to generate GAL4/+ and UAS-
CYFIP-IR/+ progeny respectively that served as controls. Tissue-specific GAL4 
expression was achieved using the tissue-specific GAL4 promoters as follows: pan-
neuronal (Elav), in cholinergic (Cha-Gla4), and GABAergic (Gad-Gal4). To avoid 
neurodevelopmental problems and possible lethality, the ElavGal4, was combined 
with the temporal TubGal80ts system (McGuire et al., 2003; McGuire et al., 2004). At 
18°C, TubGal80ts is expressed and binds GAL4, prohibiting its binding to the UAS (i.e., 
no transcription of UAS-CYFIP-IR). In contrast, at 29-30°C TubGal80ts is degraded 
and will release GAL4 which in turn will bind the UAS thus activating transcription of 
UAS-CYFIP-IR. As a result, expression of CYFIP will be downregulated. All 
flies/progeny for promoter-Gal4;TubGal80ts and their controls were cultured at 18°C 
and 2-days after eclosion were placed at 29-30°C allowing UAS-CYFIP-IR 
transcription. For Ca2+ imaging, flies were generated that express either 
synaptophysin-GCaMP (Pech et al., 2015) under control of the specific promoter 
GAL4 line (Zars et al., 2000). The Ca2+ sensors were amplified from pUAST vectors 




al., 2013). The w pink1B9 flies were kindly provided by Patrik Verstreken 
(VIB/KULeuven) and described in (Morais et al., 2009). The ndufs3 flies were kindly 
provided by Brett Graham (Baylor College of Medicine, Houston) and the idh3a flies 
described in (Ugur et al., 2017) were a gift from Hugo Bellen (Baylor College of 
Medicine, Houston). All the other transgenic flies used in this study were purchased 
from the Bloomington stock center. 
All the behavioral experiments in flies were performed in a walk-in chamber by 
Fitoclima Aralab (https://www.aralab.pt/), that offers highly precise and reproducible 
conditions for climatic and temperature testing. 
 
Drosophila single Pair Mating Assay. Social performance of the Cyfip85.1/+ flies was 
next investigated by observing courtship, a complex innate Drosophila behavior. 
Briefly, courting Drosophila males perform a characteristic sequence of behaviors: 
orienting toward and following the female, tapping her with their forelegs, vibrating one 
wing, licking her genitalia, and attempting to copulate (Bastock, 1956; Bastock, 1955; 
Ejima and Griffith, 2007; Sokolowski, 2001, 2010). 
Five to seven days-old virgin males and females were used. Each assay consisted of 
one Cyfip85.1/+ male and one wild type female introduced into a plexiglass-mating 
chamber (1 cm diameter × 4 mm height). The courtship activities were video recorded 
until successful copulation, or longer (6 minutes) in the absence of copulation, using 
a 65X SD camcorder (Samsung) mounted on a tripod. The assays were done under 
ambient light at 22 °C temperature and 70% humidity. From the videos recording the 
courtship index (CI) was calculated for each male. Briefly, CI is the fraction of total 
recording times the male performed courtship behaviors (orienting, chasing, tapping, 
licking, singing, copulation attempts) (Ejima and Griffith, 2007; Siegel and Hall, 1979; 
Sokolowski, 2001, 2010).  
 
Drosophila quantitative assay for social events (competition for food). Assays 
were performed on socially experienced, 3–7 days-old male flies. Groups of eight 
males from the same genotype were anesthetized 24 h prior to the assay and placed 
in vials with food. On the day of the assay, the males were transferred without 
anesthesia to an empty vial and were deprived of food for 90 minutes, after which they 
were exposed to a food droplet and given 2 minutes to acclimate to this disturbance. 




social event encounters scored. Behavioral assays were conducted in a behavioral 
chamber (25 °C, 60-70% humidity) between 8 a.m. and 11 a.m. Statistics were 
calculated using a one-way fixed effect ANOVA model, Kruskal Wallis test in 
combination with Dunn’s multiple comparison test. A group of male flies were tested 
simultaneously to obtain an average of the total number of social events in 2 minutes 
(i.e. number of total approaches, lunges, tussles, wing threat and initiation of courtship 
scored) (Dankert et al., 2009). The index of approaches in such a complex set up (8 
flies) was used to quantify behavior. 
 
Grooming behavior. Flies of 5 days old were collected the day before the assay and 
kept in vials with fresh food. The day of the experiment they were anesthetized by 
placing them on ice for 2 min and then placed into a grooming chamber (circular arena 
of 1cm diameter). Flies were allowed for 20 min to acclimate and then grooming 
activity was recorded for 3 min, using a 65X SD camcorder (Samsung) mounted on a 
tripod. To measure grooming behavior, raw videos were analyzed blind to the 
genotype, calculating the time of grooming over 3 min.  
 
Social space behavior. Flies were separated by gender the day prior to each 
experiment and kept in vials with fresh food. The analysis of social space behavior 
was performed using a horizontal circular chamber (a Petri dish of 9 cm diameter) as 
described before (Simon et al., 2012). Flies were briefly anesthetized by placing them 
on ice for 2 min and placed into the chamber. Flies let to acclimate for 10 min and then 
digital images were collected after the flies reached a stable position (up to 25 min). 
Digital images were imported in Image J and an automated measure of the nearest 
neighbor to each fly was determined using our own custom R script (available upon 
request).  
Thigmotaxis behavior, flies tend to move closer to the wall of an open arena to avoid 
the central part (more threatening, centrophobicity) (Besson and Martin, 2005). The 
distance of a fly from the wall of the chamber was measured using our own custom R 
script. Graphs and statistical analysis were performed using Prism 4 (GraphPad 
Software, San Diego, CA, USA). 
 
Negative geotaxis experiment. The negative geotaxis experiment allows to evaluate 




2011). Briefly, 2-days-old control and Cyfip85.1/+ flies were transferred individually into 
polystyrene tubes. The flies were allowed to acclimate for 10 min in a dark environment 
of 25°C and 70-80% humidity illuminated by red light. Each fly was vortexed for 2 sec 
and tested twice in for negative geotaxis measuring the time the fly climbs the distance 
of 6 cm.  
 
Food intake assay. A colorimetric estimation of food intake was performed as 
previously described (Aditi et al., 2016) with some modifications. Briefly groups of 7-
days old mated male flies, entrained for under 12:12 LD (Light-dark cycle), were 
transferred onto food medium containing 2.5 % (w/v) food dye (Erioglaucine blue 
disodium salt; Sigma-Aldrich), 2% agar and 5% sucrose, and left for feeding ad libitum 
for 2 hours. After feeding the flies were washed with PBS 1X, each body was detached 
from the head and singularly homogenized in 100 μl of chilled PBS 1X and centrifuged 
at 10.000 rpm for 10 min. 50 μl of supernatant was used for absorbance recording at 
620nm using a spectrophotometer. 
 
Drosophila locomotor activity. The Drosophila Activity Monitoring (DAM) system 
from Trikinetics Inc. (Walthman, MA) was used to record the locomotor activity of flies. 
Male flies (1-week old), anesthetised on ice, were individually loaded into the 
locomotor activity-monitoring tubes, thin 5 mm diameter polycarbonate tubes 
containing 5% sucrose and 2% agar food and incubated for at least 4 days under 
12:12 LD (light - dark) conditions at 25 °C and 50-60% humidity. Light was turned on 
at 7:30 am and turned off at 7:30 pm. The DAM system software counts the number 
of times the single fly walks through an infrared beam aimed at the middle of the tube. 
Data were recorded as the number of crossings (transitions) per bin of 5-30 minutes. 
To allow the flies to recover from anaesthesia and to get acclimatized to the new 
environment from the first day was excluded from the analysis. Two independent 
experiments were performed and at least 40 flies for each genotype were analysed. 
Statistical analysis was conducted using GraphPad Prism 6.0 software. Data were 
evaluated by one-way analysis of variance (ANOVA) with Sidak’s post hoc test and by 
non-parametric Kruskal-Wallis’s test with Dunn’s correction.  
 
Western Blotting analysis. For Western blot analysis, male fly heads were 




acrylamide gels, transferred to PVDF membranes and probed with primary antibodies. 
The primary antibodies used: anti-Syntaxin (DSHB) at 1:3000, anti-GAD1 (kind gift of 
Prof. Job Jackson), anti-ATP5B (Abcam) at 1:4000, anti-NDUFS3 (Abcam) at 1:4000, 
anti-HSP60 (Santa Cruz) at 1:4000, anti-Tom20 (Santa Cruz Biotech) at 1:1000, anti-
VDAC/Porin (Abcam) at 1:2000, anti-Bruchpilot (DSHB) at 1:500, and anti-Tubulin 
(DSHB) at 1:4000. Detection was obtained using the Odyssey infrared imaging system 
(LI-COR, Bioscience). The fluorescence secondary antibodies DyLight 800 anti-rabbit 
and DyLight 800 anti-mouse were used at 1:5000 (Thermo Scientific).  
 
RNA Extraction, RT-PCR and quantitative PCR (qPCR). Total RNA, from 30 male 
fly heads 1 week old, was extracted using Trizol reagent (Invitrogen, Carlsbad, CA) 
according to manufacturer’s instructions to extract total RNA. Before proceeding with 
the RT-PCR, RNA quantity and quality were determined with the NanoDrop 2000 UV-
Vis Spectrophotometer (Thermo, USA). Four independent samples for each genotype 
and 2 biological replicates have been collected. 
Total RNA was diluted to prepare aliquots of 200 ng/10 µl and used in RT-PCR 
reaction for 1 h at 37 °C, using random primers, M-MLV enzyme (Invitrogen), buffer 
5x M-MLV reaction buffer, RNAase out and dNTPs, according to manufacturer’s 
instructions (Invitrogen). cDNA was diluted 1:20 and 5 µl cDNA was used for each 
qPCR 15 µl reaction. qPCR was conducted on a Light Cycler 96 (Roche, Switzerland) 
with SYBR Green PCR mix (Roche, Switzerland) with primers of our genes of interest: 
Cyfip, gad, and ribosomal proteins L13 and L32 (encoding for the 60S ribosomal 
protein L13 and L32 respectively). All primer pairs were designed through the Fly 
Primer Bank (www.flyrnai.org/flyprimerbank) and were synthesized by IDT (Belgium) 
and Microsynth AG (Switzerland). 
Two technical replicates for each biological replicate were assessed. Statistical 
analysis was conducted using GraphPad Prism 6.0 software (La Jolla, CA). Data were 
evaluated by one-way analysis of variance (ANOVA) with Sidak’s post hoc test and by 
Kruskal-Wallis’s test with Dunn’s correction or Mann-Whitney test.  
Quantitative PCR for mtDNA content. Drosophila whole DNA (genomic and 
mitochondrial) from adult brains was obtained using a method previously described 
(Yoon et al., 2017). The isolated DNA was used for qPCR as described above. Primers 
against the mitochondrial ribosomal protein 16S and the ribosomal protein L13 were 




Polysomes/mRNPs gradient  
The protocol was slightly modified from (Napoli et al., 2008). Specifically, Drosophila 
heads were homogenized in lysis buffer (100 mM NaCl, 10 mM MgCl2, 10 mM Tris-
HCL pH 7.5, 0.5 mM DTT, Protease inhibitor cocktail, 50 μg/mL CHX, RNAse OUT 
and RNAsin inhibitor 2.5 μl/mL). The lysates were incubated 5 min on ice and then 
centrifuged 5 min at 1000 g. In the supernatant Triton-X 20% and NaDoc 10% was 
added. Samples were then centrifuged 8 min at 12000g at 4oC and the supernatants 
centrifuged through 15%-50% (w/v) sucrose grandients for 2 hours at 37.000 rpm. 
Gradients were collected in 12 fractions. Equal volumes from each fraction was used 
for RNA extraction using Phenol-Chloroform-Isoammilic alcohol (according to 
manufacturer’s conditions). 2 pg/μl of spike in Firefly Luciferase (FLuc) mRNA, 
(Promega) was added as loading control. The mRNA was used for RT and quantitative 
PCR as described in the manuscript. Aralar mRNA level (Aralar primer For: 
TCCTGGGACTCTTTTCCGAAT; Aralar primer Rev: GCCTGGAACTCCGAGAAGG) 
was normalized to Fluc mRNA level (FLuc Primer For: 
ATCTGCCTCCTGGCTTCAAC; FLuc Primer Rev: CGGTAGACCCAGAGCTGTTC). 
 
Drosophila drug administration. All compounds were purchased from Sigma-
Aldrich and were used as described before (Kanellopoulos et al., 2012; Zwarts et al., 
2011). The drugs were dissolved as per the manufacturer's instructions and used at 
the following concentrations: GABA at 50 μM, DABA 100 μM, Valproic acid (VPA) at 
1 mM, Diazepam at 50 μM, Rotenone at 1-10 μM, Pyridoxal 5’ phosphate (PLP) at 50 
μM, and Oligomycin at 500 μM. Compounds in solution were mixed with Formula 4-
24® Instant Drosophila Medium (blue food) in water. Approximately 50–60 adult flies 
were placed in plastic vials containing 500 μl of each solution on top of an agar matrix 
and allowed to feed ad libitum before behavior. Vehicle treatment consisted of solvent 
added to blue food alone.  
 
Immunohistochemical analysis. Fly brains were dissected under a 
stereomicroscope in phosphate-buffered saline 1x (PBS) for no longer than 1 hour and 
fixed in PBS 1x containing 3,7% formaldehyde for 10-15 minutes at room temperature 
using a rotator. After 3 washes of 10 minutes in PBT (PBS 1x, 0.3% Triton-X) the 
brains were blocked in 10% Normal Goat Serum in PBT for 30 minutes. The brains 




1:500, anti-GAD (DSHB) at 1:250, in 5% NGS in PBT at 4 °C overnight. After the 
primary antibody incubation, the brains were washed in PBT 3 times for 10 minutes 
per wash and incubated with secondaries Alexa Fluro 546 or 488 (Life Technologies, 
USA) at 1:1000 in 5% NGS in PBT for 1-2 hours at room temperature (RT). Then the 
brains were washed again in PBT for 3 times at RT for 10 minutes and mounted in 
Mowiol containing DAPI (1:1000) on a glass slide. Pictures were taken on the Olympus 
FluoView™ FV1000 Confocal Microscope and analyzed with ImageJ software.  
For the TMRE (Enzo) and Rhodamine 123 (Sigma-Aldrich) stainings, brains were 
dissected in HL3 solution (mM): 110 NaCl, 5 KCl, 10 NaHCO3, 5 Hepes, 30 sucrose, 
5 trehalose, and 10 MgCl2, pH 7.2. Dissected brains were stained with 10nM TMRE 
or Rhodamine123 dye for 5 minutes at room temperature. Brains were quickly washed 
with HL3 solution, mounted on glass slides and immediately imaged with confocal 
microscope Leica SP8 using the same settings for all the samples. 
 
FACS Analysis. To isolate the GABAergic neuronal population from Drosophila brain, 
the enhancer-trap line Gad-GAL4 was used to drive the expression of GFP in 
GABAergic neurons of wild type and Cyfip85.1/+ flies. Brains from adult flies (n = 60) 
per genotype were dissected in cold 1xPBS. Tissues were dissociated using 0.05% 
trypsin-EDTA (Life Technologies) for 60 minutes at 37 °C in the dark. The GFP-
positive cells were fractionated from the GFP negative population using a BD 
FACSAria I by BD Biosciences (San Jose) with a 70 μm nozzle tip at 60psi.  GFP was 
excited by a blue laser (488nm) and detected using a 530/30 bandpass (BP) filter.  
Dead cells were excluded using propidium iodide (PI) at a final concentration of 1 
μg/ml and detected using a 610/20 BP filter. Post sort purity check was performed to 
ensure clean fractionation of both the GFP-positive and -negative populations. Data 
were analyzed and presented with FlowJo software (Tree Star, Ashland, OR).  
 
Ca2+ Imaging. Control and Cyfip85.1/+ flies were generated to express the synaptically 
targeted Ca2+ sensitive fluorescent protein G-CaMP3 in the GABAergic neurons. 
Brains of male transgenic flies (seven days old) expressing synaptophysin-GCaMP 
(Pech et al., 2015) under direct control of the mb247-promoter (Pech et al., 2013) were 
imaged at a frame rate of 5 Hz and for 100 ms per frame at 488 nm through a window 
cut into the head capsule using a upright fluorescence microscope (Zeiss Examiner 




camera (Coolsnap HQ, Photometrics) and a 20 × water-immersion objective (NA 
=1.0). 50 µl of freshly prepared 1M KCl were injected into the Ringer's solution 
covering the brain (final concentration at the brain ~0.05M). Image acquisition was 
controlled using the software Metafluor (Visitron Systems, Puchheim). Image 
processing and analysis was performed with Fiji software. Circular regions of interest 
(ROIs, diameter ~20 µm) were placed in the center of the calyx or on the lobes. 
Background fluorescence outside the neuropils was subtracted from each ROI, "F0" 
was determined by the average pixel intensity of five frames directly before stimulus 
onset, ΔF is the difference between the fluorescence in each frame and F0, and 
resulting values were normalized by dividing by F0. The experimental flies were 
heterozygous for the sensor in either the w1118 background only or carrying the 
Cyfip85.1/+ mutation. Both controls and mutant flies were measured alternately on the 
same days.  
 
Mass Spectrometry. Sample was dissolved in Laemmli buffer and run on a 10% SDS-
PAGE gel, which was stopped when the front reached about 1/5 of the gel. The gel 
was fixed overnight and stained briefly with colloidal coomassie blue. The protein-
containing gel piece was chopped into 1 mm by 1 mm pieces, destained, and 
subjected to trypsin digestion as described previously (Chen et al., 2015). The tryptic 
peptides were dissolved in 17 µL 0.1M acetic acid, and analyzed by nano-LC MS/MS 
using an Ultimate 3000 LC system (Dionex, Thermo Scientific) coupled to a TripleTOF 
5600 mass spectrometer (Sciex). Peptides were fractionated on a 200 mm Alltima C18 
column (100 μm i.d., 3 μm particle size). The acetonitrile concentration in the mobile 
phase was increased from 5 to 30% in 90 minutes, to 40% in 5 minutes, and to 90% 
in another 5 minutes, at a flow rate of 400 nL/minutes. The eluted peptides were 
electro-sprayed into the TripleTOF MS. The nano-spray needle voltage was set to 
2500V. The mass spectrometer was operated in a data-dependent mode with a single 
MS full scan (m/z 350−1200, 250 msec) followed by a top 25 MS/MS (85 msec per 
MS/MS, precursor ion > 90 counts/s, charge state from +2 to +5) with an exclusion 
time of 16 sec once the peptide was fragmented. Ions were fragmented in the collision 
cell using rolling collision energy, and a spread energy of 10eV. The MS raw data were 
imported into MaxQuant (version 1.5.2.8), and searched against the uniprot-
proteome_fruitfly_%3AUP000000803 database, with match between run enabled. 





Database analysis. Orthology mapping was obtained using the DRSC DIOPT tool 
(Hu et al., 2011) that makes use of the following resources: Ensembl Compara (Vilella 
et al., 2009), NCBI Homologene, Inparanoid, Isobase, OMA, OrthoDB, OrthoMCL, 
Phylome, RoundUp and TreeFam.  
 
Disease Enrichment. We investigated disease enrichment of the union dataset 
(mapped to 278 human genes) using gene-disease annotation data collected from 
OMIM (Amberger et al., 2015), GeneRIF (Mitchell et al., 2003) and Ensembl variation 
(Chen et al., 2010a) databases using the topOnto package 
(https://github.com/statbio/topOnto). The annotation data was standardized using 
MetaMap (Aronson and Lang, 2010) and NCBO Annotator to recognize terms found 
in the Human Disease Ontology (HDO) (Schriml et al., 2012). Recognized disease 
ontology terms were then associated with gene identifiers and stored locally. Disease 
term enrichment, for the 279 human genes, were then be calculated using the 
Topology-based Elimination Fisher method (Alexa et al., 2006) found in the topGO 
package (http://topgo.bioinf-mpi-inf.mpg.de/), together with the standardized 
OMIM/GeneRIF/Ensembl variation gene-disease annotation data (17731 gene-
disease associations), and the full HDO tree (3140 terms). We tested the dataset for 
functional enrichment using the GO Cellular Component (CC) and Biological Function 
(BP) ontologies (Ashburner et al., 2000), together with the topGO package and 
Elimination Fisher method. We found 1078 (1692) CC terms for Fly (Human) and 6479 
(14291) BP terms (See Supplemental Tables). Enrichment results are shown in Figure 
2, where P-values have been corrected using the Bonferroni correction at the 0.01 
(***) and 0.05 (**) significance level, using the number of terms in the GO tree. 
 
Construction of PPI networks from external Databases. The fly PPI network was 
built using the total 361 genes found, together with interactions extracted from the 
publicly available databases: FlyBase, BioGRID, IntAct, BIND, DIP, MINT.The fly PPI 
network was filtered to contain only interactions between the 361 genes found the final 
largest connected component contains 274 genes and 1014 interactions. The network 
was found to have overall associative mixing (0.097), driven by main contributors 




from the 278 human orthologs, was found to consist of 234 genes and 1143 
interactions. 
The fly PPI network consisting of 274 genes and 1014 interactions, using the Vision 
visualization package (http://visone.info/html/) and clustered using the Modularity 
based Potts model and simulated annealing algorithm “spinglass” (Reichardt and 
Bornholdt, 2006; Traag and Bruggeman, 2009) available in R 
(http://igraph.sourceforge.net)  (spin states set to 500, and gamma to 2.0). Genes are 
highlighted using GO annotation with “mitochondrion” (GO:0005739)  related genes in 
peach, “cytoskeleton” related genes in navy blue, and “synaptic vesicle” related genes 
in orange. For each cluster in the fly PPI network found, we further tested the 
significance of enrichment for function and disease, using the Hypergeometric 
distribution for sampling without replacement: 






𝑃 − 𝑣𝑎𝑙𝑢𝑒(𝜇𝑓𝑐) = ∑ {
𝑃(𝑋 = 𝑖) : 𝑃(𝑋 = 𝑖) ≤ 𝑃(𝑋 = 𝜇𝑓𝑐)




Where in eqn-1, N is the total number of genes in the network; Cn the number of genes 
in the community; F the total number of functional annotated genes in the network, 
and 𝜇𝑓𝑐  the number of functional annotated genes per community. P-values were 
tested for their strength of significance, by recording the percentage of P-values found 
from every community/annotation combination, lower than or equal to the observed P-
value, when 1000 random permutations of the annotation labels were made. A 
pseudocount of 1 was added to avoid permutated P-values of zero. P-values found 
with a strength of significance < 1% were considered statistically significant. 
Functionally enriched clusters, for GO “mitochondrion”, “cytoskeleton” and “synaptic 
vesicle” related annotations are also highlighted. 
Gene ontology analysis for genetic screening. 178 Drosophila genes were associated 
to GO “mitochondrial outer membrane” (GO:0005741). Out of 178, 43 genes were 
selected that were described to be involved in transport (excluding protons, electrons 
transport and OXPHOS). From the 43 genes, we obtained 36 available mutant fly 
strains from the Bloomington Drosophila Stock Center (NIH P40OD018537) and used 





Metabolite quantification. Both groups of metabolites, amino acids and TCA cycle 
intermediates, were quantified using stable-isotope-dilution Liquid Chromatography 
Mass Spectrometry (LC-MS) as described below. Snap frozen brain samples were 
pre-extracted and homogenized by the addition of 100 µL of MeOH:H2O (4:1) per 10 
fly brains (2 x 20 seconds at 10000 rpm, Cryolys Precellys Homogenizer, Bertin 
Technologies, Rockville, MD, US). Homogenized extracts were centrifuged (15 
minutes at 4000 g at 4°C) and the resulting supernatant was evaporated to dryness in 
a vacuum concentrator (LabConco, Missouri, US). Total protein content was 
measured in pellets using the BCA assay. Dried sample extracts were resuspended 
in 50µL of MeOH:H2O (4:1, v/v) and mixed with 250µL of the ice-cold internal standard 
solution (in 100% acetonitrile). Samples were then incubated 30 minutes at -80°C in 
order to promote protein precipitation and centrifuged 15 minutes at 4°C and 2700g. 
The resulting supernatants were injected for LC-MS analysis.  
Quantification of amino acids was performed using Hydrophilic Interaction Liquid 
Chromatography coupled to high resolution mass spectrometry (HILIC - HRMS) in 
positive ionization mode using a QExactive™ Hybrid Quadrupole-Orbitrap interfaced 
with Thermo Accela 1250 UPLC pump and CTC PAL Analytics autosampler. 
Metabolites were separated using a BEH Amide, 1.7 μm, 100 mm × 2.1 mm I.D. 
column (Waters, Massachusetts, US). The mobile phase was composed of A = 20 mM 
ammonium formate and 0.1 % FA in water and B = 0.1 % FA in ACN. The linear 
gradient elution from 95% B (0-2 minutes) to 65% B (14 minutes) and down to 50% B 
(16 – 18 minutes) was applied, followed by 4 minutes of column re-equilibration in the 
initial gradient conditions. The flow rate was 400µL/minutes and the sample injection 
volume was 10 µL. HESI source conditions were set as follow: sheath gas flow at 60, 
Aux gas flow rate at 20, Sweep gas flow rate at 0, spray voltage at +3kV, capillary 
temperature at 300°C, s-lens RF level at 60 and aux gas heater temperature at 300°C. 
The instrument was set to acquire over the mass range 60−900, with the MS 
acquisition parameters set as follows: resolution at 70’000 FWHM, 1 microscan, 1e6 
AGC and maximum inject time at 100 ms. Amino acids and derivatives were quantified 
by using a standard calibration curves and isotopic labeled internal standards. LC-MS 
data was processed using TraceFinder Clinical Research (version 4.1, Thermo 
Fischer Scientific). 
Quantification of TCA cycle intermediates was performed using Hydrophilic Interaction 




negative ionization mode using a 6495 Triple Quadrupole system (QqQ) interfaced 
with 1290 UHPLC system (Agilent Technologies). TCA metabolites were separated 
using a ZIC-pHILIC (100 mm, 2.1 mm I.D. and 5 µm particle size) column. The mobile 
phase was composed of A = 20 mM ammonium Acetate and 20 mM NH4OH in water 
at pH 9.35 and B = 100% ACN. The linear gradient elution from 90% B (0-1.5 minutes) 
to 50% B (8 – 11 minutes) and down to 45% B (12 – 15 minutes) was applied, followed 
by 9 minutes of column re-equilibration using the initial gradient conditions. The flow 
rate was 300 μL/minutes, column temperature 30°C and sample injection volume 2µl. 
ESI source conditions were set as follows: dry gas temperature 290 °C and flow 14 
L/minutes, sheath gas temperature 350 °C, nebulizer 45 psi, and flow 12 L/minutes, 
nozzle voltage 0 V, and capillary voltage -2000 V. Data were acquired in a Dynamic 
Multiple Reaction Monitoring (DMRM) mode with a total cycle time of 600 msec. 
Collision energies were optimized for each metabolite. LC-MS/MS data was 
processed using the Agilent Quantitative analysis software (version B.07.00, 
MassHunter Agilent technologies). Relative quantification of metabolites was based 
on EIC (Extracted Ion Chromatogram) areas for the monitored MRM transitions.  
For absolute quantification, calibration curves and the stable isotope-labeled internal 
standards (IS) were used and the concentrations of the compounds were calculated 
as the ratio of MS response (peak area) between the analyte and the IS, to account 
for matrix effects. Finally, the concentrations were reported to total protein content in 
brain tissue. 
For isotope tracing, flies were fed with sucrose free food containing [U-13C]-glucose 
for 6 hours and immediately dissected in cold PBS 1x. For each sample ten drosophila 
brains were pre-extracted and homogenized as described above. Brain extracts were 
analyzed by Hydrophilic Interaction Liquid Chromatography coupled to high resolution 
mass spectrometry (HILIC - HRMS) in negative ionization mode using a 6550 
Quadrupole Time-of-Flight (Q-TOF) system interfaced with 1290 UHPLC system 
(Agilent Technologies) as previously described (Gallart-Ayala et al., 2018). Raw LC-
MS files were processed in Profinder B.08.00 software (Agilent Technologies) using 
the targeted data mining in isotopologue extraction mode. The metabolite identification 
was based on accurate mass and retention time matching against an in-house 
database containing data on 600 polar metabolite standards (analyzed in the same 
analytical conditions). The Extracted Ion Chromatogram areas (EICs) of each 




(Midani et al., 2017) and the label incorporation or 13C enrichment was calculated 
based on relative isotopolgue abundance (in %), in each one of two analyzed 
conditions (Roci et al., 2016). 
 
Mitochondrial Functional Assays. High resolution respirometry. For measuring 
mitochondrial respiration in Drosophila brains: ten fly heads from 4 days old male were 
rapidly dissected under a microscope and mechanically homogenized in Miro6 Buffer 
(20 mM Hepes, 110 mM sucrose, 10 mM KH2PO4, 20 mM taurine, 60 mM lactobionic 
acid, 3 mM MgCl2, 0.5 EGTA, pH 7.1, 1 mg/ml fatty acid free BSA, catalase 280 U/ml) 
(Krumschnabel et al., 2015), then immediately and loaded into an Oroboros 2K 
oxygraph chamber filled with Miro6 buffer equilibrated at 25 °C. 
Drosophila bodies. For mitochondrial respiration in fly bodies, fly heads were rapidly 
removed and bodies were mechanically permeabilized in Miro6 Buffer. The body 
homogenates were then spun at 200 g for 5 minutes and the supernatant was 
immediately loaded into the Oroboros 2K oxygraph. In each of these protocols, the 
intactness of the mitochondrial outer membrane was checked by addition of 
exogenous cytochrome c.  
Oxygen consumption rates were measured before and after addition of the following 
sequence of substrates and specific inhibitors: 1) 2.5 mM pyruvate, 1 mM malate in 
flies, and a mixture of 2.5 mM pyruvate, 10 mM glutamate, and 1 mM malate in human 
cells (CI leak), followed by 2.5 mM ADP to determine complex I-driven phosphorylating 
respiration (CI OXPHOS). 2) 5 mM succinate to determine the phosphorylating 
respiration driven by simultaneous activation of complex I and II (CI+II OXPHOS). 3) 
Titrating concentrations of the mitochondrial uncoupler CCCP to reach the maximal, 
uncoupled respiration (CI+II electron transfer system, ETS). 4) 200 nM rotenone to 
fully inhibit complex I-driven respiration and measure complex II-driven uncoupled 
respiration (CII electron transfer system, CII ETS). 5) 0.5 µM Antimycin A to block 
mitochondrial respiration at the level of complex III. Residual oxygen consumption was 
always negligible. 6) 2 mM ascorbate, 0.5 mM TMPD to measure cytochrome c 
oxidase (CIV or COX)- driven respiration. 7) 300 µM potassium cyanide to specifically 
block cytochrome c oxidase activity and measure residual background oxygen 
consumption caused by chemical interaction between ascorbate and TMPD. 




NADH and NADt levels were measured from brain lysates using the NAD/NADH 
Quantitation Colorimetric Kit (Biovision, K337). The enzyme activity of IDH was 
determined from isolated mitochondria using the BioVision kit (K756-100). 
Mitochondria were isolated as previously described (Depner et al., 2014; Yoon et al., 
2017).  
Citrate synthase (CS) activity was measured using the MAK193 assay kit (Sigma-
Aldrich). Briefly, isolated mitochondria from 100 fly brains were used for measuring 
the CS activity. CS activity was calculated using a coupled enzyme reaction, which 
leads in a colorimetric (412 nm) product proportional to the enzymatic activity present. 
One unit of CS is the enzyme that generates 1.0 mmole CoA per min at 25°C and pH 
7.2. The absorbance was measured in a microplate photometer at 412 nm.  
 
Electron microscopy. Fly brains from 3-5 days old flies were dissected in cold PBS 
1x and fixed over-night in 2% paraformaldehyde and 2.5% gluteraldehyde in 0.1 M 
sodium cacodylate buffer pH 7.4. After rinsing in 0.1 M cacodylate buffer, the samples 
were post fixed in 1:1 2% OsO4 and 0.2 M cacodylate buffer for 1 hour. After 3 water 
washes, samples were dehydrated in a graded ethanol series and embedded in an 
epoxy resin (Sigma-Aldrich). Ultrathin sections (60-70 nm) were obtained with an 
Ultrotome V (LKB) ultramicrotome, counterstained with uranyl acetate and lead citrate 
and viewed with a Tecnai G2 (FEI) transmission electron microscope operating at 100 
kV. Images were captured with a Veleta (Olympus Soft Imaging System) digital 
camera. Quantification of mitochondria perimeter and area was performed by using 
ImageJ software.  
 
ELISA. GABA levels were determined from fly brains using the GABA ELISA Enzyme 
immunoassay (IBL, ID59301). Briefly, total brain lysates, isolated mitochondria and 
vesicles (Depner et al., 2014; Yoon et al., 2017) were used for GABA derivatization. 
The samples were incubated with a polyclonal antibody against GABA-derivative, 
together with assay reagent containing GABA-derivative (tracer). The concentration of 
antibody-bound tracer is inverse proportional to the GABA concentration in the 
sample. Peroxidase conjugate was added detect the tracer and tetramethylbenzidine 
(TMB) served as a peroxidase substrate. The absorbance was measured in a 
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Figure 1. Deficits in social behavior in flies harboring the Cyfip 
haploinsufficiency. (A) Control (w1118), Cyfip85.1/+, TM3/+ and Cyfip85.1/TM3 flies 
were analyzed for total number of social interactions in a competition for food assay. 
n > 20 groups of 8 flies each or (B) in a courtship assay. n > 20 flies. (C) Grooming 
behavior. The percentage of time spent grooming was monitored over a period of 3 
minutes in control and Cyfip85.1/+ flies. n = 10-12 individual flies for each genotype. (D) 
Social space behavior. Left, representative images of an open field assay. Red circles 
indicate flies staying close together. Middle, quantification of the distance of a fly to its 
closest neighbor in control and Cyfip85.1/+ flies. n = 8 groups of 30 flies for each 
genotype. Right, Cyfip85.1/+ flies keep longer distance from the wall of an open arena. 
n = 8 replicates of 30 flies for each genotype. For all paradigms data are shown with 
box and whisker plots where the line inside the box indicates the median, ****p < 
0.0001, ***p < 0.001, **p < 0.01, Mann–Whitney test. 
 
Figure 2. Cyfip haploinsufficiency proteome revealed maladaptive 
mitochondrial function and energy production. (A) Clustering of the Fly CYFIP PPI 
network. The Modularity-based Potts and simulated annealing algorithms available in 
R. were used.  GO "mitochondrion" related genes are shown in peach, "cytoskeleton" 
related genes in navy-blue, and "synaptic vesicle" related genes in orange. Enriched 
clustered, using the Hypergeometric test corrected for using a permutation study, for 
"mitochondrion", "cytoskeleton" and "synaptic vesicle" related GO terms are also 
highlighted. Community 3, p = 2.4 x 10-6, permutated p = 0% and Community 18, p = 
0.0194816, permutated p = 0.92375%. (B) Gene ontology cellular component analysis 
and (C) Gene ontology biological functions analysis of Cyfip85.1/+ flies compared to 
controls. Enrichment values were calculated using the Topology-based Elimination 
Fisher method. (D) Disease enrichment values for the deregulated genes of Cyfip85.1/+ 
flies compared to controls using combined OMIM/geneRIF/Ensembl variation 
annotation data. Enrichment values were calculated using the Topology-based 
Elimination Fisher method; N = number of disease genes found in the dataset; p-





Figure 3. Increased brain mitochondrial activity, membrane potential and size in 
Cyfip haploinsufficient flies. (A) A representative graph of high-resolution 
respirometry experiment in control and Cyfip85.1/+ fly brains. The blue line represents 
the oxygen concentration and the red line the oxygen consumption flux. (B) 
Quantification of the oxygen consumption normalized per unit (1 unit corresponding to 
1 brain) of control and Cyfip85.1/+. n ≥ 6 independent experiments per genotype (each 
with 10 fly brains), mean ± s.e.m. **p < 0.01, multiple t test, corrected for multiple 
comparisons using the Sidak-Bonferroni method. (C) Same as in (B) of Cyfip85.1/+ fly 
bodies (no heads). Normalization by protein concentration mg. n ≥ 7 independent 
experiments per genotype, mean ± s.e.m. ns, not significant, multiple t-test, corrected 
for multiple comparisons using the Sidak-Bonferroni method. (D) Measurement of the 
mitochondrial membrane potential. Left, representative Z projections of confocal 
images of fly brains stained with TMRE. The antenna lobes (AL) area was quantified. 
The antenna lobes (AL) area was quantified (highlighted with a red circle). Right, 
quantification of the TMRE staining from control and Cyfip85.1/+. Shown is the fold 
change in TMRE fluorescence intensity from the AL area. n = 15-16 brains per 
genotype, mean ± s.e.m., **p < 0.01, Mann–Whitney test. (E) Mitochondrial DNA copy 
number measured in control and Cyfip85.1/+ fly brains relative to nuclear DNA. n = 4 
(groups of 10 fly brains), mean ± s.e.m, ns, not significant, Mann-Whitney test. (F) Left, 
representative EM images of mitochondria from control and Cyfip85.1/+ fly brains. Right 
panel, quantification of the mitochondria perimeter and area. n = 160-165 mitochondria 
per genotype, mean ± s.e.m. ****p < 0.0001, Mann–Whitney test. 
 
Figure 4. Altered TCA cycle and metabolism in Cyfip haploinsufficient flies.  (A) 
Simplified representation of TCA cycle and metabolites measured in fly brains. (B) 
Quantification of metabolites from the TCA cycle in Cyfip85.1/+ brains normalized to 
control. n = 5 (groups of 10 fly brains), mean ± s.e.m. ***p < 0.001, **p < 0.01, *p < 
0.05, Kruskal-Wallis test, Dunn’s multiple comparison test. (C) Enzymatic activity of 
IDH-NAD dependent from Cyfip85.1/+ brains normalized to control. n = 3-4 (group of 
10 fly brains), mean ± s.e.m. **p < 0.01, Mann-Whitney test. (D) same as in (C) for 
αKG enzymatic activity. n = 3-4 (groups of 10 fly brains), mean ± s.e.m. *p < 0.05, 
Mann-Whitney test. (E) Relative levels of NAD total and (F) NADH of fly brains from 
control and Cyfip85.1/+. n = 4 (groups of 10 fly brains), mean ± s.e.m. *p < 0.05, Mann-




Drosophila brain tissue following 6 hours feeding with [13C]glucose. The x-axis denotes 
the 13C-isotopologue profile (i.e. the mass isotopologue distribution - MID) of labeled 
metabolites following the incorporation of [13C] glucose skeleton. The catabolism of 
13C labeled glucose leads to M+3 pyruvate. The decarboxylation of pyruvate makes 
M+2 acetyl-CoA in the mitochondria, which is then incorporated into M+2 citrate. All 
TCA cycle intermediates, downstream of citrate, will have a mass of M+2. Values 
shown are mean ± sem. n = 5 (10 brains were pooled per each sample). ***p < 0.001, 
**p < 0.01, *p < 0.05, Sidak's multiple comparisons test. 
 
Figure 5. TCA cycle and mitochondrial complex I inhibition restores social 
deficits in Cyfip mutant flies.  
(A) Social behavior of Cyfip85.1/+ upon genetic reduction of idh3a, n > 10 groups of 8 
flies for each genotype were analyzed, ***p < 0.001, **p < 0.01, Kruskal-Wallis test, 
Dunn’s multiple comparison test. (B) Social behavior upon treatment with 5 μM of 
ML309 for 1 (1d) or 3 days (3d) of Cyfip85.1/+ flies and (C) upon pan-neuronal IDH 
overexpression (29oC) in adults. n > 10 groups of 8 flies for each genotype, **p < 0.01, 
****p < 0.0001, ***p < 0.001, Kruskal-Wallis test, Dunn’s multiple comparison test. (D) 
Quantification of the oxygen consumption normalized per unit upon treatment with 5 
μM of ML309 for 3 days (3d) of control and Cyfip85.1/+. n ≥ 4 independent experiments 
per genotype (each with 10 fly brains), mean ± s.e.m. *p < 0.05, multiple t test, 
corrected for multiple comparisons using the Sidak-Bonferroni method. (E) 
Competition for food upon feeding with 10 μM rotenone for 1 (1d), 2 (2d) and 4 days 
(4d) in Cyfip85.1/+ flies and (F) upon genetic reduction of pink1 or ndufs3, n > 10 groups 
of 8 flies for each genotype were analyzed, ****p < 0.0001, Kruskal-Wallis test, Dunn’s 
multiple comparison test. 
 
Figure 6. Social deficits in Cyfip85.1/+ flies are due to defects in GABA signalling. 
(A) Abrogation of Cyfip in cholinergic, (B) GABAergic neurons and (C) in subsets of 
interneurons in the anterior paired lateral neurons (APLGal4), antenna lobe 
interneurons (LN1Gal4, LN2Gal4), and the dorsal paired medial neurons (DPMGal4). 
Flies were analyzed for total number of social interactions in a food competition assay. 
n = 14 groups of 8 flies per genotype, ****p < 0.0001, ***p < 0.001, **p < 0.01, Kruskal-
Wallis test, Dunn’s multiple comparison test. (D) Left, representative Z projections of 




50 μM GABA and stained with α-GABA. Right, data quantification (n = 15 brains). 
Scale bars, 100 μm. ****p < 0.0001, Kruskal-Wallis test, Dunn’s multiple comparison 
test. (E) Expression of syp-pHTomato in GABAergic neurons to measure synaptic 
release. (F) Dynamics and maximal change of monitored syp-pHTomato fluorescence 
in GABAergic neurons of control and Cyfip85.1/+ flies.  n = 10 flies. All traces indicate 
mean ± s.e.m. The scale bars represent 20 μm; *p < 0.05; two-sample t test. (G) GABA 
levels determined by HILIC-MS/MS in control and Cyfip85.1/+ brains. n = 5 (groups of 
10 brains) per genotype, mean ± s.e.m, ns, not significant, Mann-Whitney test. (H) 
Analysis of GABA levels from control and Cyfip85.1/+, into enriched fractions of 
mitochondria and vesicles by ELISA. n > 3, mean ± s.e.m. **p < 0.01, Kruskal-Wallis 
test, Dunn’s multiple comparison test. (I) Competition for food of Cyfip85.1/+ flies upon 
treatment (2-5 days) with 50 μM GABA, n > 10 groups of 8 flies, ****p < 0.0001, ***p 
< 0.001, **p < 0.01, Kruskal-Wallis test, Dunn’s multiple comparison test. 
 
Figure 7. Aralar is a novel mitochondrial GABA transporter. (A) Genetic screening 
for changes in competition for food behavior. Flies mutant for mitochondrial carriers 
were crossed with Cyfip85.1/+ mutant flies, tested and compared to control and 
Cyfip85.1/+ flies. Threshold line indicates the control levels of behavior. # shows the 
genotype that is significantly different from Cyfip85.1/+ and not different from the control. 
mean ± s.e.m, n > 10 groups of 8 flies, Kruskal-Wallis test, Dunn’s multiple comparison 
test. (B) Competition for food, (C) grooming behavior and (D) social space behavior in 
control, Cyfip85.1/+ and AralarMI07552/Cyfip85.1 flies. n > 8 independent experiments with 
groups of 8 and 30 flies in (B) and (D), respectively. All comparisons refer to the 
control. ***p < 0.001, **p < 0.01, *p < 0.05, Kruskal-Wallis test, Dunn’s multiple 
comparison test. (E) Analysis of GABA levels by ELISA in cytosolic and mitochondrial 
fractions from control, Cyfip85.1/+, AralarMI07552/+ and AralarMI07552/Cyfip85.1 flies. n > 3, 
mean ± s.e.m. **p < 0.01, *p < 0.05, Kruskal-Wallis test, Dunn’s multiple comparison 
test. (F) Upon treatment with 500 μΜ oligomycin, mitochondrial membrane potential 
was analyzed by staining using TMRE, n = 8-9 brains. (G) Competition for food of 
control flies upon treatment (1 day) with 500 μM of oligomycin, n = 10 groups of 8 flies 
each. (H) GABA levels measured by ELISA in fractionated mitochondria. n = 5, mean 





Figure 8. Model. Aralar drives GABA uptake into polarized mitochondria. When 
Cyfip level is reduced, the TCA cycle produces increased levels of succinate and 
NADH leading to higher mitochondrial activity that next leads to hyperpolarization of 
mitochondria. As a consequence, the increased polarization activates the GABA 
carrier Aralar driving GABA into mitochondria. The excessive unidirectional GABA 
transport into the mitochondria reduces its homeostatic levels required for proper 
synapse functioning and behavior. 
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Kanellopoulos et al.  Supplemental Information 
 
Figure and Table Legends 
 
Figure S1. Cyfip haploinsufficiency flies have deficits in social behavior and 
hyperactivity. (A) Female Cyfip85.1/+ flies show a decreased competition for food. 
Control (w1118) and Cyfip85.1/+ female flies were analyzed for total number of social 
interactions in a competition for food assay. n > 12 groups of 8 flies. Data are shown 
with box and whisker plots where the line inside the box indicates the median, ***p < 
0.001, Mann–Whitney test. (B, C) Male Cyfip85.1/+ flies are hyperactive. (B) 
Locomotion activity of control and Cyfip85.1/+ flies was monitored over 24 hours and 
(C) during the morning period ZT0-ZT6. n > 40 flies for each genotype were tested. 
mean ± s.e.m., **p < 0.01, ns, not significant, Mann–Whitney test. (D, E) No negative 
geotaxis phenotype in Cyfip85.1/+ flies. Negative geotaxis response was measured in 
5 days old Cyfip85.1/+ and control male (D) and female (E) flies. n > 30 flies for each 
genotype, mean ± s.e.m. ns, not significant, Mann–Whitney test. (F) Cyfip mRNA 
levels are decreased in adult brains upon pan-neuronal Cyfip knockdown (29oC) in 
comparison to parental control strains. The levels of Cyfip were normalized to rpl13 
mRNA. n = 3 for each genotype, mean ± s.e.m. *p < 0.05, Kruskal-Wallis test, Dunn’s 
multiple comparison test. (G) Acute knock down of Cyfip in adult male flies is sufficient 
to produce the phenotype in the competition for food assay. Adult-specific abrogation 
of Cyfip (UAS-CYFIP-IR) (29°C) pan-neuronally compared with uninduced (18°C), 
transgene-alone and driver-alone control flies were analyzed for total number of social 
interactions. Conditional overexpression of CYFIP in the mutant background (genetic 
rescue, UAS-CYFIP, Cyfip85.1/+) in comparison with the uninduced transgene (18°C) 
reverses social defects of Cyfip85.1/+ flies. n = 14 independent experiments with 8 flies 
per genotype, ****p < 0.0001, **p < 0.01, Kruskal-Wallis test, Dunn’s multiple 
comparison test. 
 
Figure S2. The proteome of the Cyfip85.1/+ mutant flies revealed maladaptive 
mitochondrial function and altered TCA cycle. (A) Electron transport chain and (B) 
TCA cycle modified from WikiPathways (wikipathways.org) for Drosophila 
melanogaster. Proteomic analysis of Cyfip85.1/+ flies uncovered several dysregulated 
mitochondrial proteins (highlighted) in comparison to control flies. 
Kanellopoulos et al. Supplemental Text
 
Figure S3. Increased mitochondrial Complex I subunit in Cyfip85.1/+ fly brains. 
(A) Mitochondrial membrane potential is increased in Cyfip85.1/+ brains. Left, 
representative Z projection of confocal images of fly brains from control and Cyfip85.1/+ 
stained with Rhodamine 123. Right, quantification of fold change in Rhodamine 123 
fluorescence intensity from the antenna lobes (AL) area. n = 11-12 brains per 
genotype, mean ± s.e.m., *p = 0.0167, Kruskal-Wallis test, Dunn’s multiple 
comparison test. (B, C) Upregulation of Complex I subunit NDUFS3 in Cyfip85.1/+ flies 
(B) Left panel, representative Western blotting of protein extracts from fly brains using 
antibodies to detect the mitochondrial proteins HSP60, ATPB, NDUFS3 and TOM20. 
Right panel, quantification upon normalization to Syntaxin, n = 4 per genotype, mean 
± s.e.m *p < 0.05. Kruskal-Wallis test, Dunn’s multiple comparison test. (C) 
VDAC/Porin level does not change in the Cyfip85.1/+ flies. Left panel, representative 
Western blotting of protein extracts from fly brains using an antibody to detect the 
mitochondrial marker VDAC/Porin. Right panel, quantification upon normalization to 
Tubulin, n = 4 per genotype, mean ± s.e.m, ns, not significant, Mann–Whitney test. 
(D) Citrate synthase (CS) activity does not change in the Cyfip85.1/+ flies. 
Measurement of mitochondrial CS activity in control and Cyfip85.1/+ fly brains. n = 5 
per genotype, mean ± s.e.m., ns, not significant, Mann–Whitney test. (E, F) Feeding 
behavior is not altered in the Cyfip85.1/+ flies. (E) Food consumption during the day 
time. Groups of 5-7-day-old flies were analyzed every 2 hours (ZT0, ZT2, ZT4, ZT6). 
(F) Quantification of food consumption over 24 hours (see Methods). At the given time 
points, flies were collected, homogenized, and the absorbance of the supernatant 
measured at 625 nm (to read the blue dye in the food). mean ± s.e.m., ns, not 
significant, Mann–Whitney test.  
 
Figure S4. Cyfip85.1/+ fly brains have high levels of amino acids related to the 
TCA cycle. (A) Liquid chromatography-mass spectrometry revealed that specific 
amino acids related to the TCA cycle are higher in Cyfip85.1/+ brains compared to 
control flies. Amino acids in Cyfip85.1/+ brains normalized to control and μg of protein 
(n = 5, groups of 10 fly brains), mean ± s.e.m. *p < 0.05, **p < 0.01, Kruskal-Wallis 
test, Dunn’s multiple comparison test. (B) Specific chemical reactions of the TCA cycle 
are affected in the Cyfip85.1/+ brains. Contribution of [U-13C6] glucose to the TCA-cycle 
metabolites such as glutamate, glutamine and aspartate in Drosophila brain tissue 
following 6 hours feeding with [13C] glucose. The x-axis denotes the 13C-isotopologue 
profile (i.e. the mass isotopologue distribution - MID) of labeled metabolites following 
the incorporation of [13C] glucose skeleton. The catabolism of 13C labeled glucose 
leads to M+3 pyruvate. The decarboxylation of pyruvate makes M+2 acetyl-CoA in the 
mitochondria, which is then incorporated into M+2 citrate. All the TCA cycle 
intermediates, downstream of citrate, have a mass of M+2. Values shown are 
mean ± sem (n = 5, 10 brains were pooled per each sample). * p < 0.05; ** p< 0.01, 
***p < 0.001, 2way ANOVA, Sidak's multiple comparisons test. 
 
Figure S5. Rotenone treatment restores social deficits but does not restore 
hyperactivity of Cyfip85.1/+ flies. (A) Rotenone treatment does not affect control flies. 
Competition for food upon treatment with different concentrations of rotenone in 
control flies. (B) The positive effect of rotenone treatment is reversible in Cyfip85.1/+ 
flies. Cyfip mutant flies were treated for 4 days (4d) with 10 μΜ rotenone and then 
tested for 5 days of the post-treatment period in competition for food assay. The 
comparison was with the control in each case. n > 10 groups of 8 flies for each 
condition were tested. mean ± s.e.m., ****p < 0.0001, **p < 0.01, Kruskal-Wallis test, 
Dunn’s multiple comparison test. (C) Rotenone does not rescue hyperactivity in 
Cyfip85.1/+ flies. Locomotion upon treatment with 10 μΜ rotenone for 4 days (4d) was 
analyzed in Cyfip85.1/+ flies. Locomotion was monitored over 24 hours. n > 40 flies for 
each condition were tested. mean ± s.e.m., ** p< 0.01, Kruskal-Wallis test, Dunn’s 
multiple comparison test. 
 
Figure S6. GABA-dependent excitability and number of GABAergic neurons are 
not affected in the Cyfip85.1/+ flies. (A) Decreased Cyfip mRNA levels upon Cyfip 
knockdown in GABAergic neurons (FACS sorted cells) (white bar) in comparison to 
control flies (black bar). The levels of Cyfip were normalized to rpl13 mRNA. n = 3 for 
each genotype, mean ± s.e.m. **p < 0.01, Mann–Whitney test. (B) Scheme of the 
GABAergic neuronal subsets where CYFIP was knock-down. APL (GABAergic and 
Octopaminergic) and DPM (GABAergic and Serotonergic). The LN (GABAergic) 
neurons regulate the Projections neurons (PN). (C) No changes in presynaptic 
excitability. Representative false color-coded image showing pre-synaptic Ca2+ influx 
in GABAergic (n > 8) and APL (n > 6) neurons upon depolarization (50 mM KCl). The 
traces indicate the dynamics of Ca2+ influx, quantified as ΔF/F0 (%) in synaptophysin-
G-CaMP fluorescence over time (t0 indicates KCl delivery). The bar diagram indicates 
Max ΔF/F0 (%). mean ± s.e.m, p > 0.05, Mann-Whitney test. (D-F) No changes in the 
number of GABAergic neurons. (D) Left, representative Z projections of confocal 
images of control and Cyfip85.1/+ fly brains stained with nc82 (neuropil) and GAD1 
antibody. Right, quantification of GAD1 relative fluorescence (n > 11). White box 
indicates the area of quantification. Scale bar, 100 μm. Mann-Whitney test. (E) Left, 
representative Western blotting of GAD1 levels from control and Cyfip85.1/+ adult head 
lysates. Left, quantification of relative levels to neuronal marker syntaxin. n = 4, mean 
± s.e.m, Mann-Whitney test. (F) Real-time PCR detecting Gad1 mRNA level 
normalized to rpl13 mRNA. n = 3 for each genotype, mean ± s.e.m, Mann-Whitney 
test.  
 
Figure S7. GABA supplement restores social deficits in Cyfip haploinsufficient 
flies. (A) No changes in glutamate levels as determined by HILIC-MS/MS in control 
and Cyfip85.1/+ brains. n = 5 (group of 10 brains) per genotype, mean ± s.e.m, Mann-
Whitney test. (B) Subcellular fractionation and enrichment in mitochondria and 
synaptosomes.  Shown is a Western blot of the respective fractions. Bruchpilot (BRP) 
was used as synaptic marker and ATP5B was used as mitochondrial marker. (C-E) 
Increasing GABA availability rescues competition for food behavior.  (C) Competition 
for food of Cyfip85.1/+ flies upon treatment (2-5 days) with 100 μM DABA, and (D) 1 
mM VPA. (E) Conditional abrogation (29°C) of CYFIP pan-neuronally in adults upon 
GABA treatment for 5 days in comparison with the uninduced (18°C) and induced 
(29°C) controls. Flies tested for social interactions.  n > 14 independent experiments 
(group of 8 flies) for each genotype, mean ± s.e.m., ***p < 0.001, Kruskal Wallis test, 
Dunn’s multiple comparison test. (F) Decreased GABA production phenocopies Cyfip 
mutation. Competition for food upon GAD1 abrogation pan-neuronally in adults. n > 
10 independent experiments (each with 8 flies) for each genotype, mean ± s.e.m., ***p 
< 0.001, Kruskal-Wallis test, Dunn’s multiple comparison test. (G) Excess of GABA 
affects behavior in control flies. Competition for food was monitored upon treatment 
with 50μM GABA for 5 days (5d), in control flies. n > 10 independent experiments 
(each with 8 flies) for each genotype, mean ± s.e.m., *p < 0.05, Mann-Whitney test. 
(Η) GABAAR agonist rescues CYFIP mutant behavior. Competition for food of 
Cyfip85.1/+ flies upon treatment (1d) with 50 μM Diazepam. (I) Competition for food 
was rescued upon treatment with VPA, GABA, DABA, in flies with reduced CYFIP in 
GABAergic neurons. For all the experiments n > 10 (group of 8 flies), **p < 0.01, ***p 
< 0.001, ****p < 0.0001, Kruskal-Wallis test, Dunn’s multiple comparison test. (J) 
Temporal effect of GABA treatment in competition for food. Cyfip85.1/+ flies were 
treated for 5 days with GABA (GABA 5d) and then tested for 5 days of the post-
treatment period.  The comparison was with the control in each case. n > 10 groups 
of 8 flies for each condition were tested. mean ± s.e.m., ****p < 0.0001, **p < 0.01, 
Kruskal-Wallis test, Dunn’s multiple comparison test. 
 
Figure S8: Characterization of Aralar synthesis in Cyfip haploinsufficiency. (A) 
Aralar haploinsufficiency does not rescue hyperactivity deficits of Cyfip mutant flies.  
Locomotor activity was monitored over 24 hours. n > 40 flies for each genotype were 
tested. mean ± s.e.m., **p < 0.01, ***p < 0.001, Kruskal-Wallis test, Dunn’s multiple 
comparison test. (B) Aralar inhibition by pyridoxal 5'-phosphate (PLP) restores social 
deficits in Cyfip haploinsufficient flies. Competition for food of control and Cyfip85.1/+ 
flies upon treatment (2 days) with 50 μM PLP. n > 10 (groups of 8 flies each), **p < 
0.01, *p < 0.05, Mann–Whitney test. (C, D) Aralar expression does not change in the 
Cyfip85.1/+ flies. (C) Aralar mRNA level was measured in control and Cyfip85.1/+ fly 
brains by RT-qPCR and quantified upon normalization to the ribosomal protein l13 
mRNA. n = 4 (groups of 10 fly brains each), mean ± s.e.m, Mann-Whitney test (D) 
Translational efficiency of Aralar mRNA is comparable in control and Cyfip85.1/+ flies. 
Distribution of Aralar mRNA on polysomes and mRNPs. Bars indicate the percentage 
Aralar mRNA on polysomes over the total (polysomes + mRNPs). n = 3 groups of 100 
fly heads for each genotype, mean ± s.e.m. Mann–Whitney test. 
 
Table S1. List of the identified proteins in control and Cyfip85.1/+ fly brains.  
 
Table S2. GO biological functions and cellular components in control and 
Cyfip85.1/+ fly brains.   
 
Table S3. GO analysis of mitochondrial GABA carrier candidates. 
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GO.ID  GO Biological Function Annotated Significant classic Fisher Elim Fisher Hits
GO:0000022 mitotic spindle elongation 82 19 5.5e-13 5.50E-13 19
GO:0006457 protein folding 104 20 5.5e-12 5.50E-12 20
GO:0006099 tricarboxylic acid cycle 39 13 1.7e-11 1.70E-11 13
GO:0006096 glycolytic process 27 10 1.2e-09 1.20E-09 10
GO:0015986 ATP synthesis coupled proton transport 21 9 1.8e-09 1.80E-09 9
GO:0007269 neurotransmitter secretion 122 23 2.1e-13 6.10E-09 23
GO:0048790 maintenance of presynaptic active zone s... 6 5 9.0e-08 9.00E-08 5
GO:0051298 centrosome duplication 85 15 9.0e-09 2.70E-07 15
GO:0008103 oocyte microtubule cytoskeleton polariza... 23 7 1.9e-06 1.90E-06 7
GO:0048172 regulation of short-term neuronal synapt... 5 4 2.7e-06 2.70E-06 4
GO:0006537 glutamate biosynthetic process 6 4 8.1e-06 8.10E-06 4
GO:0000281 mitotic cytokinesis 65 10 1.0e-05 1.00E-05 10
GO:0007317 regulation of pole plasm oskar mRNA loca... 29 7 1.0e-05 1.00E-05 7
GO:0015991 ATP hydrolysis coupled proton transport 40 8 1.1e-05 1.10E-05 8
GO:0009408 response to heat 87 11 2.5e-05 2.50E-05 11
GO:0008340 determination of adult lifespan 160 15 3.5e-05 3.50E-05 15
GO:0006414 translational elongation 24 6 3.7e-05 3.70E-05 6
GO:0006120 mitochondrial electron transport, NADH t... 35 7 3.9e-05 3.90E-05 7
GO:0045454 cell redox homeostasis 49 8 5.1e-05 5.10E-05 8
GO:0016082 synaptic vesicle priming 16 5 5.2e-05 5.20E-05 5
GO:0051130 positive regulation of cellular componen... 189 18 4.6e-06 5.50E-05 18
GO:0006108 malate metabolic process 9 4 6.3e-05 6.30E-05 4
GO:0007274 neuromuscular synaptic transmission 70 9 0.00012 0.00012 9
GO:0008104 protein localization 522 41 1.2e-09 0.00016 41
GO:0006119 oxidative phosphorylation 84 18 9.5e-12 0.00018 18
GO:0007009 plasma membrane organization 47 7 0.00027 0.00027 7
GO:0006886 intracellular protein transport 261 23 8.6e-07 0.00030 23
GO:0008360 regulation of cell shape 114 11 0.00030 0.00030 11
GO:0007520 myoblast fusion 48 7 0.00031 0.00031 7
GO:0009612 response to mechanical stimulus 48 7 0.00031 0.00031 7
GO:0000398 mRNA splicing, via spliceosome 270 25 1.1e-07 0.00033 25
GO:0051881 regulation of mitochondrial membrane pot... 6 3 0.00039 0.00039 3
GO:0000381 regulation of alternative mRNA splicing,... 65 8 0.00039 0.00039 8
GO:0007067 mitotic nuclear division 265 18 0.00039 0.00039 18
GO:0022900 electron transport chain 88 18 2.2e-11 0.00044 18
GO:0016183 synaptic vesicle coating 14 4 0.00045 0.00045 4
GO:0033227 dsRNA transport 25 5 0.00052 0.00052 5
GO:0045451 pole plasm oskar mRNA localization 68 13 3.3e-08 0.00057 13
GO:0048488 synaptic vesicle endocytosis 53 10 1.5e-06 0.00059 10
GO:0051533 positive regulation of NFAT protein impo... 15 4 0.00060 0.00060 4
GO:0007298 border follicle cell migration 125 11 0.00066 0.00066 11
GO:0030721 spectrosome organization 7 3 0.00066 0.00066 3
GO:0031629 synaptic vesicle fusion to presynaptic m... 7 3 0.00066 0.00066 3
GO:0055114 oxidation-reduction process 556 53 1.2e-15 0.00071 53
GO:1901215 negative regulation of neuron death 27 5 0.00075 0.00075 5
GO:0000028 ribosomal small subunit assembly 2 2 0.00075 0.00075 2
GO:0000447 endonucleolytic cleavage in ITS1 to sepa... 2 2 0.00075 0.00075 2
GO:0000461 endonucleolytic cleavage to generate mat... 2 2 0.00075 0.00075 2
GO:0006086 acetyl-CoA biosynthetic process from pyr... 2 2 0.00075 0.00075 2
GO:0042062 long-term strengthening of neuromuscular... 2 2 0.00075 0.00075 2
Fly brain
Table S2. GO biological functions and cellular components analysis of control and Cyfip 85.1/ + mutant 
flies.
GO:0043525 positive regulation of neuron apoptotic ... 2 2 0.00075 0.00075 2
GO:0046598 positive regulation of viral entry into ... 2 2 0.00075 0.00075 2
GO:2000427 positive regulation of apoptotic cell cl... 2 2 0.00075 0.00075 2
GO:0007406 negative regulation of neuroblast prolif... 28 5 0.00089 0.00089 5
GO:0006090 pyruvate metabolic process 37 15 1.6e-14 0.00095 15
GO:0030865 cortical cytoskeleton organization 50 9 7.5e-06 0.00101 9
GO.ID  GO Cellular Component Annotated Significant classic Fisher Elim Fisher Hits
GO:0005811 lipid particle 207 86 1.00E-30 1.00E-30 86
GO:0005875 microtubule associated complex 369 82 1.00E-30 1.00E-30 82
GO:0022627 cytosolic small ribosomal subunit 40 14 3.8e-12 3.80E-12 14
GO:0005737 cytoplasm 3313 250 1.00E-30 2.50E-11 250
GO:0005759 mitochondrial matrix 161 25 9.9e-12 3.40E-09 25
GO:0045169 fusome 36 11 4.3e-09 4.30E-09 11
GO:0008021 synaptic vesicle 71 14 1.7e-08 1.70E-08 14
GO:0030018 Z disc 33 10 2.4e-08 2.40E-08 10
GO:0043195 terminal bouton 42 11 2.6e-08 2.60E-08 11
GO:0022625 cytosolic large ribosomal subunit 54 12 4.5e-08 4.50E-08 12
GO:0031430 M band 9 6 5.2e-08 5.20E-08 6
GO:0071011 precatalytic spliceosome 147 18 3.6e-07 3.60E-07 18
GO:0071013 catalytic step 2 spliceosome 125 16 8.8e-07 8.80E-07 16
GO:0005739 mitochondrion 656 82 3.4e-30 9.90E-07 82
GO:0000275 mitochondrial proton-transporting ATP sy... 9 5 2.6e-06 2.60E-06 5
GO:0005829 cytosol 823 71 1.1e-16 2.70E-06 71
GO:0043025 neuronal cell body 66 11 3.4e-06 3.40E-06 11
GO:0005747 mitochondrial respiratory chain complex ... 49 9 1.2e-05 1.20E-05 9
GO:0005703 polytene chromosome puff 38 8 1.3e-05 1.30E-05 8
GO:0031594 neuromuscular junction 54 9 2.7e-05 2.70E-05 9
GO:0005743 mitochondrial inner membrane 193 37 5.1e-20 5.30E-05 37
GO:0048786 presynaptic active zone 16 5 7.6e-05 7.60E-05 5
GO:0070938 contractile ring 16 5 7.6e-05 7.60E-05 5
GO:0030122 AP-2 adaptor complex 4 3 0.00010 0.00010 3
GO:0098800 inner mitochondrial membrane protein com... 129 28 7.0e-17 0.00024 28
GO:0005853 eukaryotic translation elongation factor... 5 3 0.00025 0.00025 3
GO:0045254 pyruvate dehydrogenase complex 5 3 0.00025 0.00025 3
GO:0000221 vacuolar proton-transporting V-type ATPa... 13 4 0.00045 0.00045 4
GO:0045170 spectrosome 6 3 0.00049 0.00049 3
GO:0005874 microtubule 64 8 0.00059 0.00059 8
GO:0000276 mitochondrial proton-transporting ATP sy... 14 4 0.00061 0.00061 4
GO:0033181 plasma membrane proton-transporting V-ty... 14 4 0.00061 0.00061 4
GO:0098803 respiratory chain complex 87 17 5.7e-10 0.00064 17
GO:0005813 centrosome 98 10 0.00066 0.00066 10
GO:0005746 mitochondrial respiratory chain 88 17 6.8e-10 0.00078 17
GO:0045495 pole plasm 39 6 0.00095 0.00095 6
GO:0045172 germline ring canal 27 5 0.00107 0.00107 5
GO:0048471 perinuclear region of cytoplasm 55 7 0.00116 0.00116 7
GO:0005886 plasma membrane 933 56 2.7e-07 0.00127 56
GO:0005832 chaperonin-containing T-complex 8 3 0.00131 0.00131 3
GO:0005890 sodium:potassium-exchanging ATPase compl... 8 3 0.00131 0.00131 3
GO:0015629 actin cytoskeleton 107 16 9.9e-08 0.00143 16
GO:0030140 trans-Golgi network transport vesicle 9 3 0.00192 0.00192 3
GO:0008091 spectrin 3 2 0.00260 0.00260 2
GO:0031475 myosin V complex 3 2 0.00260 0.00260 2
GO:0035062 omega speckle 3 2 0.00260 0.00260 2
GO:0008541 proteasome regulatory particle, lid subc... 10 3 0.00269 0.00269 3
GO:0016460 myosin II complex 10 3 0.00269 0.00269 3
GO:0072686 mitotic spindle 35 5 0.00354 0.00354 5
GO:0044444 cytoplasmic part 2582 212 1.00E-30 0.00369 212
GO:0030424 axon 112 18 4.8e-09 0.00399 18
GO:0008540 proteasome regulatory particle, base sub... 12 3 0.00472 0.00472 3
GO:0019773 proteasome core complex, alpha-subunit c... 12 3 0.00472 0.00472 3
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